Timothy J. Wilt
#100,087
Most Influential Person Now
Timothy J. Wilt's AcademicInfluence.com Rankings
Timothy J. Wiltphilosophy Degrees
Philosophy
#3876
World Rank
#6189
Historical Rank
Logic
#1475
World Rank
#2238
Historical Rank
Download Badge
Philosophy
Why Is Timothy J. Wilt Influential?
(Suggest an Edit or Addition)Timothy J. Wilt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. (1999) (3049)
- Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. (2017) (1638)
- Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. (2009) (1486)
- Radical prostatectomy versus observation for localized prostate cancer. (2012) (1359)
- The Association of Registered Nurse Staffing Levels and Patient Outcomes: Systematic Review and Meta-Analysis (2007) (1094)
- Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society (2011) (981)
- Immunotherapy for advanced renal cell cancer. (2015) (608)
- Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer (2008) (603)
- KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. (2015) (587)
- Screening for prostate cancer. (2013) (542)
- Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. (2011) (466)
- Integration of mental health/substance abuse and primary care. (2008) (449)
- Single-Therapy Androgen Suppression in Men with Advanced Prostate Cancer (2000) (448)
- Follow‐up of Prostatectomy versus Observation for Early Prostate Cancer (2017) (430)
- Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline from the American College of Physicians (2007) (409)
- Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. (1998) (388)
- Prevention and early detection of prostate cancer. (2014) (357)
- Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients (2006) (326)
- Intravesical bacillus Calmette‐Guérin is superior to mitomycin C in reducing tumour recurrence in high‐risk superficial bladder cancer: a meta‐analysis of randomized trials (2004) (313)
- Nurse staffing and quality of patient care. (2007) (288)
- Teledermatology for diagnosis and management of skin conditions: a systematic review. (2011) (285)
- Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians (2017) (285)
- Predictors and prevalence of erectile dysfunction in a racially diverse population. (2006) (283)
- Effectiveness of statin therapy in adults with coronary heart disease. (2004) (276)
- Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis (2009) (272)
- The functional outcomes of total knee arthroplasty. (2005) (266)
- A systematic review of intravesical bacillus Calmette‐Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer (2001) (266)
- Phytoestrogens for Treatment of Menopausal Symptoms: A Systematic Review (2004) (264)
- Prevalence, Assessment, and Treatment of Mild Traumatic Brain Injury and Posttraumatic Stress Disorder: A Systematic Review of the Evidence (2011) (262)
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials. (2002) (260)
- Systematic Review: Randomized, Controlled Trials of Nonsurgical Treatments for Urinary Incontinence in Women (2008) (259)
- Medical Management to Prevent Recurrent Nephrolithiasis in Adults: A Systematic Review for an American College of Physicians Clinical Guideline (2013) (255)
- Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma (2002) (254)
- Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. (2006) (251)
- Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians (2018) (251)
- Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials (2011) (250)
- Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. (1995) (246)
- Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2018) (231)
- Systematic Review: Effective Management Strategies for Lactose Intolerance (2010) (221)
- Antimicrobial Stewardship in Outpatient Settings: A Systematic Review (2014) (218)
- Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. (2010) (216)
- Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. (2002) (214)
- A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. (2009) (199)
- Serenoa repens for benign prostatic hyperplasia. (2000) (197)
- Meta-analysis: Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes (2011) (196)
- Screening for prostate cancer: an updated Cochrane systematic review (2011) (190)
- The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. (1994) (186)
- AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. (2010) (182)
- Phytotherapy for benign prostatic hyperplasia (2000) (181)
- Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. (2008) (177)
- Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. (2001) (177)
- Advanced Wound Care Therapies for Nonhealing Diabetic, Venous, and Arterial Ulcers (2013) (174)
- Fecal Microbiota Transplantation for Clostridium difficile Infection (2015) (174)
- Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians (2016) (168)
- Lower urinary tract symptoms increase the risk of falls in older men (2009) (167)
- Bisphosphonates for advanced prostate cancer. (2006) (164)
- Serenoa repens for benign prostatic hyperplasia. (2012) (163)
- Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. (2009) (163)
- Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline (2012) (161)
- Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients and Those With Stroke: A Background Review for an American College of Physicians Clinical Practice Guideline (2011) (159)
- Screening for cancer: advice for high-value care from the American College of Physicians. (2015) (158)
- A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice? (2004) (151)
- Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer. (2000) (148)
- Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. (2006) (148)
- Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review (2014) (142)
- The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer. (2012) (138)
- Pygeum africanum for benign prostatic hyperplasia. (1998) (137)
- Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). (2005) (128)
- Chemotherapy for hormone-refractory prostate cancer. (2006) (128)
- Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline (2007) (128)
- Lactose intolerance and health. (2010) (126)
- Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review. (2001) (124)
- Male urinary incontinence: prevalence, risk factors, and preventive interventions. (2009) (124)
- Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. (2019) (124)
- Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors (2004) (123)
- Prevention of urinary and fecal incontinence in adults. (2007) (122)
- Comparative Effectiveness of Clostridium difficile Treatments (2011) (122)
- The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. (2009) (121)
- Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. (1999) (121)
- Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. (2009) (119)
- Targeted therapy for advanced renal cell carcinoma. (2008) (115)
- Antiviral Therapy for Adults With Chronic Hepatitis B: A Systematic Review for a National Institutes of Health Consensus Development Conference (2009) (114)
- Association between hospital and surgeon radical prostatectomy volume and patient outcomes: a systematic review. (2008) (114)
- Diagnosis and Treatment of Chronic Abacterial Prostatitis (2000) (113)
- Beta-sitosterols for benign prostatic hyperplasia. (1999) (113)
- Epidemiology of High-Grade Prostatic Intraepithelial Neoplasia (2000) (112)
- Systematic Review: Repair of Unruptured Abdominal Aortic Aneurysm (2007) (111)
- Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review. (2005) (109)
- Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. (2009) (106)
- Intravesical gemcitabine therapy for non‐muscle invasive bladder cancer (NMIBC): a systematic review (2012) (105)
- Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. (2000) (104)
- Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians (2019) (104)
- Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians (2016) (102)
- Pharmacist-Led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care (2016) (102)
- Pelvic floor muscle training to improve urinary incontinence after radical prostatectomy: a systematic review of effectiveness (2007) (101)
- Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer. (2015) (100)
- Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: a systematic review and meta-analysis of randomized controlled trials. (2001) (100)
- The prostate cancer intervention versus observation trial (PIVOT). A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer (1995) (100)
- Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review (2012) (99)
- Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline. (2012) (97)
- Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. (2003) (96)
- Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer (2008) (91)
- Comparison of endovascular and open surgical repairs for abdominal aortic aneurysm. (2006) (90)
- Transition to the new race/ethnicity data collection standards in the Department of Veterans Affairs (2006) (90)
- A systematic review of Cernilton for the treatment of benign prostatic hyperplasia (2000) (89)
- Screening for prostate cancer: A Cochrane systematic review (2007) (87)
- Surgery versus radiotherapy for muscle invasive bladder cancer? (2001) (82)
- Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). (1997) (80)
- Diagnosis and management of ductal carcinoma in situ (DCIS). (2009) (80)
- Wheeled Mobility (Wheelchair) Service Delivery: Scope of the Evidence (2012) (79)
- A value framework for cancer screening: advice for high-value care from the American College of Physicians. (2015) (78)
- Screening of prostate cancer. Is it needed? Russian experience (2006) (77)
- Evidence Report/Technology Assessment (2003) (77)
- Alfuzosin for treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: a systematic review of efficacy and adverse effects. (2005) (76)
- Laser prostatectomy for benign prostatic obstruction. (2000) (76)
- Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020. (2020) (76)
- Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (2019) (75)
- Prostate cancer screening and the management of clinically localized disease (2013) (75)
- Can we deliver randomized trials of focal therapy in prostate cancer? (2014) (74)
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I, Initial Work-up and Medical Management. (2021) (74)
- Enhanced Recovery Protocols for Adults Undergoing Colorectal Surgery: A Systematic Review and Meta-analysis (2018) (73)
- Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake (2016) (73)
- Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. (2002) (72)
- Progression of lower urinary tract symptoms in older men: a community based study. (2010) (71)
- Microwave thermotherapy for benign prostatic hyperplasia. (2012) (71)
- Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. (2000) (71)
- Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet. (2001) (70)
- Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis. (2013) (68)
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Part II-Surgical Evaluation and Treatment. (2021) (68)
- Agreement about Indications for Total Knee Arthroplasty (2006) (68)
- Screening for syphilis infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. (2009) (68)
- Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence (2009) (67)
- Couple and family involvement in adult mental health treatment: a systematic review. (2013) (65)
- Cryotherapy for localised prostate cancer. (2007) (65)
- Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. (2007) (64)
- The prostate cancer intervention versus observation trial (1994) (64)
- Microwave thermotherapy for benign prostatic hyperplasia. (2007) (63)
- Interventions to Improve Veterans’ Access to Care: A Systematic Review of the Literature (2011) (63)
- Intravesical gemcitabine for non-muscle invasive bladder cancer. (2012) (62)
- Remdesivir for Adults With COVID-19 (2020) (62)
- Correlates and prevalence of prostatitis in a large community-based cohort of older men. (2005) (62)
- Measuring patient knowledge of the risks and benefits of prostate cancer screening. (2004) (62)
- Delirium: Screening, Prevention, and Diagnosis – A Systematic Review of the Evidence (2011) (62)
- Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention (2019) (62)
- Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in Adults (2012) (61)
- Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes - A Systematic Review of the Evidence (2012) (61)
- Participation after multidisciplinary rehabilitation for moderate to severe traumatic brain injury in adults: a systematic review. (2013) (61)
- Finasteride for benign prostatic hyperplasia. (2010) (61)
- Five-alpha-reductase Inhibitors for prostate cancer prevention. (2008) (61)
- Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points (2022) (61)
- Intermittent versus continuous androgen suppression for prostatic cancer. (2007) (60)
- Trazodone for erectile dysfunction: a systematic review and meta‐analysis (2003) (60)
- Treatment of common hip fractures. (2009) (57)
- Does Integrated Care Improve Treatment for Depression?: A Systematic Review (2011) (57)
- Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline. (2015) (56)
- An Evidence Map of the Women Veterans’ Health Research Literature (2008–2015) (2017) (55)
- Neurotoxin Treatments for Urinary Incontinence in Subjects With Spinal Cord Injury or Multiple Sclerosis: A Systematic Review of Effectiveness and Adverse Effects (2008) (54)
- Maximal androgen blockade for advanced prostate cancer. (1999) (53)
- Clinical implications of lactose malabsorption versus lactose intolerance. (2013) (53)
- Antimicrobial urinary catheters: a systematic review (2008) (52)
- Effectiveness of behavioral interventions to modify physical activity behaviors in general populations and cancer patients and survivors. (2004) (51)
- Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review (2004) (51)
- Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. (2017) (50)
- Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials. (2009) (50)
- Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. (2009) (50)
- An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. (1999) (49)
- Tamsulosin for benign prostatic hyperplasia. (2003) (49)
- 5‐α‐Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review (2010) (48)
- Screening Pelvic Examinations in Asymptomatic, Average-Risk Adult Women: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians (2014) (47)
- Impact of Diastolic and Systolic Blood Pressure on Mortality: Implications for the Definition of “Normal” (2011) (47)
- Screening for Post-Traumatic Stress Disorder (PTSD) in Primary Care: A Systematic Review (2013) (46)
- Carbohydrate and lipid disorders and relevant considerations in persons with spinal cord injury. (2008) (46)
- Effect of Exercise on Disorders of Carbohydrate and Lipid Metabolism in Adults With Traumatic Spinal Cord Injury: Systematic Review of the Evidence (2009) (45)
- Reduction in physician reimbursement and use of hormone therapy in prostate cancer. (2010) (45)
- Cernilton for benign prostatic hyperplasia. (2011) (45)
- Hypertension Limbo: Balancing Benefits, Harms, and Patient Preferences Before We Lower the Bar on Blood Pressure (2018) (45)
- Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis (2020) (44)
- Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population. (2011) (44)
- Reconsidering the Approach to Prevention Recommendations for Older Adults (2010) (44)
- Effectiveness of Family and Caregiver Interventions on Patient Outcomes in Adults with Cancer: A Systematic Review (2014) (43)
- Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects (2004) (42)
- Rural vs. Urban Ambulatory Health Care: A Systematic Review (2011) (41)
- Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study. (1989) (41)
- Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and meta-analysis of harms. (2009) (41)
- Carotid atherosclerosis in men with low levels of HDL cholesterol. (1997) (41)
- Total Knee Replacement (1976) (40)
- Intermediate- and Long-Term Cognitive Outcomes After Cardiovascular Procedures in Older Adults (2015) (39)
- Fit for purpose: perspectives on rapid reviews from end-user interviews (2017) (38)
- Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial. (2002) (38)
- Terazosin for benign prostatic hyperplasia. (1994) (38)
- Clinical Efficacy of OM-85 BV in COPD and Chronic Bronchitis: A Systematic Review (2005) (37)
- The Assessment and Treatment of Individuals with History of Traumatic Brain Injury and Post-Traumatic Stress Disorder: A Systematic Review of the Evidence (2009) (37)
- Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians (2021) (36)
- Major Update: Remdesivir for Adults With COVID-19 (2021) (35)
- Models in the Development of Clinical Practice Guidelines (2014) (35)
- Treatment interventions in nursing home residents with urinary incontinence: a systematic review of randomized trials. (2008) (32)
- The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods (2019) (32)
- Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer. (2002) (32)
- Care Interventions for People Living With Dementia and Their Caregivers (2020) (32)
- Prostate-specific antigen screening in prostate cancer: perspectives on the evidence. (2014) (31)
- Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians (2019) (31)
- Cost-effectiveness of abdominal aortic aneurysm repair: A systematic review (2007) (31)
- Interventions for chronic abacterial prostatitis. (1999) (31)
- Antimicrobial Stewardship Programs in Outpatient Settings: A Systematic Review (2014) (31)
- Disparities in total knee replacements: a review. (2007) (30)
- Effectiveness of training methods for delivery of evidence-based psychotherapies: a systematic review (2020) (30)
- Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. (2009) (29)
- Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia (2020) (29)
- Prostate cancer: epidemiology and screening. (2003) (29)
- Chapter 12: Systematic Review of Prognostic Tests (2012) (29)
- Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma (2011) (28)
- Focused Evidence Review: Psychometric Properties of Patient-Reported Outcome Measures for Chronic Musculoskeletal Pain (2018) (28)
- Lower urinary tract symptoms in men (2014) (28)
- Outcomes Associated With Blast Versus Nonblast-Related Traumatic Brain Injury in US Military Service Members and Veterans: A Systematic Review (2017) (28)
- Screening for impaired visual acuity in older adults: U.S. Preventive Services Task Force recommendation statement. (2009) (27)
- Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Summary. (2009) (27)
- Early Diagnosis, Prevention, and Treatment of Clostridium difficile: Update (2016) (27)
- Guideline group composition and group processes: article 3 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. (2012) (27)
- Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians (2020) (26)
- Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program (2008) (26)
- Evidence Brief: Role of the Annual Comprehensive Physical Examination in the Asymptomatic Adult (2011) (26)
- Risk of Bias (2012) (26)
- Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies (2012) (26)
- Cost savings associated with increased RN staffing in acute care hospitals: simulation exercise. (2009) (25)
- Clinically localised prostate cancer (2006) (25)
- Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol. (1992) (25)
- A Conceptual Framework for Understanding and Reducing Overuse by Primary Care Providers (2013) (25)
- Internal medical residents' ability to diagnose and characterize major depression. (1999) (25)
- SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care. (2008) (25)
- Assessing Harms When Comparing Medical Interventions (2008) (25)
- Neo‐adjuvant and adjuvant hormone therapy for localised prostate cancer (2006) (25)
- Cholesterol awareness after case-finding: do patients really know their cholesterol numbers? (1997) (24)
- Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee. (1995) (24)
- SAW PALMETTO EXTRACT FOR TREATMENT OF BENIGNE PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW (1999) (24)
- Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects (2002) (24)
- Treatment interventions in nursing home residents with urinary incontinence: a systematic review of randomized trials (2008) (24)
- Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake. (2017) (24)
- The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. (2010) (24)
- Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. (2012) (24)
- Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects (2007) (23)
- Effectiveness of early diagnosis, prevention, and treatment of Clostridium difficile infection (2011) (23)
- Allopurinol for chronic prostatitis. (2002) (23)
- PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice. (2015) (23)
- Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study. (1999) (23)
- Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment (2012) (23)
- The Association of Bone Mineral Density with Prostate Cancer Risk in the Osteoporotic Fractures in Men (MrOS) Study (2009) (22)
- Current strategies in the diagnosis and management of lower extremity peripheral vascular disease (1992) (22)
- Who uses decision aids? Subgroup analyses from a randomized controlled effectiveness trial of two prostate cancer screening decision support interventions (2006) (22)
- Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group. (1996) (22)
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol (2000) (22)
- Effectiveness of Family and Caregiver Interventions on Patient Outcomes Among Adults with Cancer or Memory-Related Disorders: A Systematic Review (2013) (21)
- Breast cancer screening: from science to recommendation. (2010) (21)
- Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review (2019) (21)
- Prevalence and Correlates of Symptomatic Peripheral Atherosclerosis in Individuals with Coronary Heart Disease and Cholesterol Levels Less Than 240 mg/dL: Baseline Results from the Cholesterol And Recurrent Events (CARE) Study (1996) (21)
- Effectiveness of Caregiver Interventions on Patient Outcomes in Adults With Dementia or Alzheimer’s Disease (2015) (21)
- Benign prostatic hyperplasia. Part 1—Diagnosis (2008) (21)
- Counterpoint: Randomized Trials Provide the Strongest Evidence for Clinical Guidelines The US Preventive Services Task Force and Prostate Cancer Screening (2013) (21)
- Management of Insomnia Disorder (2015) (20)
- Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia. (2011) (20)
- Tamsulosin for benign prostatic hyperplasia. (1997) (20)
- Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis (2011) (20)
- Interventions to Improve Veterans' Access to Care (2011) (19)
- Excessive antibiotic use in men with prostatitis. (2008) (19)
- The effect of fish oil supplements on blood pressure. (1993) (19)
- Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review. (2020) (19)
- WITHDRAWN: Tamsulosin for benign prostatic hyperplasia. (2011) (18)
- Benign prostatic hyperplasia. Part 2—Management (2008) (18)
- Uncertainty in prostate cancer care: the physician's role in clearing the confusion. (2000) (18)
- Prevalence and trends of selected urologic conditions for VA healthcare users (2006) (18)
- The Effects of Shared Decision Making on Cancer Screening – A Systematic Review (2014) (18)
- Early intervention or expectant management for prostate cancer. The Prostate Cancer Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancer. (1995) (18)
- Cognitive Outcomes After Cardiovascular Procedures in Older Adults: A Systematic Review (2014) (18)
- Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection (2011) (18)
- Comparative Effectiveness of Home-Based Kidney Dialysis Versus In-Center or Other Outpatient Kidney Dialysis Locations – A Systematic Review (2015) (18)
- 5-a-Reductase inhibitors for prostate cancer chemoprevention: An updated Cochrane systematic review (BJU International (2010) 106:10 (1444-1451)) (2011) (17)
- Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial (2013) (17)
- Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. (2011) (17)
- Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia (2020) (17)
- Informing patients about prostate cancer screening: identifying and meeting the challenges while the evidence remains uncertain. (2002) (17)
- Can randomized treatment trials in early stage prostate cancer be completed? (1998) (17)
- Provider Types and Outcomes in Obstructive Sleep Apnea Case Finding and Treatment (2018) (17)
- Doxazosin in the treatment of benign prostatic hypertrophy: an update (2006) (16)
- Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Review (2016) (16)
- Statin Use and Risk of Prostate Cancer in the Prospective Osteoporotic Fractures in Men (MrOS) Study (2012) (16)
- Table 1, United States Preventive Services Task Force (USPSTF) Recommendations for Physical Examination Procedures for Average Risk Asymptomatic Adults (2011) (16)
- Terazosin for treating symptomatic benign prostatic obstruction (2002) (16)
- Brief Cognitive Tests for Distinguishing Clinical Alzheimer-Type Dementia From Mild Cognitive Impairment or Normal Cognition in Older Adults With Suspected Cognitive Impairment (2020) (16)
- EPC Methods: AHRQ End-User Perspectives of Rapid Reviews (2016) (16)
- Comparative Effectiveness of Clostridium difficile TreatmentsA Systematic Review (2011) (16)
- Terazosin for benign prostatic hyperplasia. (2011) (15)
- Long-term Outcomes of Living Kidney Donation (2016) (15)
- Evidence Review—Social Determinants of Health for Veterans (2018) (15)
- Is antidepressant plus sildenafil a recipe for priapism? (2004) (15)
- Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee. (2016) (15)
- Prevalence and risk factors of fecal incontinence in community-dwelling men. (2009) (15)
- Interventions to Prevent or Delay Long-Term Nursing Home Placement for Adults with Impairments—a Systematic Review of Reviews (2020) (15)
- Prevalence and Severity of Psychiatric Disorders and Suicidal Behavior in Service Members and Veterans With and Without Traumatic Brain Injury: Systematic Review (2020) (15)
- Effect of Written and Computerized Decision Support Aids for the U.S. Agency for Health Care Policy and Research Depression Guidelines on the Evaluation of Hypothetical Clinical Scenarios (2001) (15)
- Collaborative self-management and behavioral change. (2014) (15)
- Erectile dysfunction. (2007) (14)
- Benefits and Harms of the Mediterranean Diet Compared to Other Diets (2015) (14)
- A Systematic Review of the Efficacy of Adding Nonexposure Components to Exposure Therapy for Posttraumatic Stress Disorder (2013) (14)
- Management of stable chronic obstructive pulmonary disease (2007) (14)
- Management of chronic hepatitis B. (2008) (13)
- Cernilton for benign prostatic hyperplasia (2011) (13)
- Immunotherapy for advanced renal cell cancer. (2000) (13)
- Treatment options for benign prostatic hyperplasia (2002) (13)
- Serenoa repens for benign prostatic hyperplasia (Review) (2009) (13)
- DISCUSSION AND RECOMMENDATIONS (2011) (12)
- Agency for Healthcare Research and Quality Evidence-based Practice Center methods provide guidance on prioritization and selection of harms in systematic reviews. (2018) (12)
- Immunotherapy for advanced renal cell cancer (Review) (2008) (12)
- Serenoa repens for benign prostatic hyperplasia. (2012) (12)
- Deciding what type of evidence and outcomes to include in guidelines: article 5 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. (2012) (12)
- Prostate cancer: emerging concepts. (1996) (12)
- Prostate cancer screening: practice what the evidence preaches. (1998) (12)
- Management of low risk and low PSA prostate cancer: long term results from the prostate cancer intervention versus observation trial. (2014) (12)
- Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation. (2012) (12)
- Effectiveness and Harms of High-Flow Nasal Oxygen for Acute Respiratory Failure: An Evidence Report for a Clinical Guideline From the American College of Physicians (2021) (12)
- Serenoa repens for benign prostatic hyperplasia. (2002) (11)
- Systematic Review of Prognostic Tests (2012) (11)
- The Effect of Working Conditions on Patient Care: A Systematic Review (2012) (11)
- Time to Osteoporosis and Major Fracture in Older Men: The MrOS Study. (2016) (11)
- Prostate carcinoma practice patterns (2000) (11)
- Antimicrobial Stewardship Programs in Inpatient Settings (2013) (10)
- Quality assurance questionnaire for professionals fails to improve the quality of informed consent (2007) (10)
- Sildenafil for Male Erectile Dysfunction (2002) (10)
- Diagnosis and Treatment of Erectile Dysfunction (2009) (10)
- The paucity of evidence supporting screening for stages 1-3 CKD in asymptomatic patients with or without risk factors. (2014) (10)
- Models in the development of clinical practice guidelines. (2015) (10)
- Chapter 11: Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests used as Predictive Indicators (2012) (10)
- Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery. (2012) (9)
- Expanded Access to Lung Cancer Screening-Implementing Wisely to Optimize Health. (2021) (9)
- Treatment for Restless Legs Syndrome (2012) (9)
- Family Involved Psychosocial Treatments for Adult Mental Health Conditions: A Review of the Evidence (2012) (9)
- Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease. (2014) (8)
- Effectiveness of statin therapy in adults with coronary heart disease (2004) (8)
- Commentary: controversies in NICE guidance on prostate cancer (2008) (8)
- Erectile Dysfunction and Peyronie's Disease: (2007) (7)
- Screening for Syphilis Infection in Pregnancy (2009) (7)
- Prostate cancer (non-metastatic). (2003) (7)
- Prostate cancer intervention (2003) (7)
- Reducing PSAnxiety: The importance of noninvasive chronic disease management in prostate cancer detection and treatment. (2004) (7)
- The if's, and's, or but's regarding bisphosphonates for prostate cancer. (2007) (7)
- Bringing an Organizational Perspective to the Optimal Number of Colorectal Cancer Screening Options Debate (2012) (6)
- Systematic Review: Outcomes by Duration of NPO Status prior to Colonoscopy (2017) (6)
- Safe and Effective Anticoagulation in the Outpatient Setting: A Systematic Review of the Evidence (2011) (6)
- Care Coordination Models and Tools—Systematic Review and Key Informant Interviews (2021) (6)
- Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review (2019) (6)
- The Comparative Effectiveness, Harms, and Cost of Care Models for the Evaluation and Treatment of Obstructive Sleep Apnea (OSA): A Systematic Review (2016) (6)
- Use of Left Ventricular Assist Devices as Destination Therapy in End-Stage Congestive Heart Failure: A Systematic Review (2012) (6)
- Allopurinol for chronic prostatitis. (2002) (6)
- Health screening needs independent regular re-evaluation (2021) (6)
- Pharmacist-Led Chronic Disease Management (2015) (5)
- Chronic Kidney Disease Stages 1–3 (2012) (5)
- Physician performance and patient perceptions during the rectal examination (1991) (5)
- Value of Prostate Cancer Care: New Information on New Therapies Suggest Less is More. (2017) (5)
- Planning controlled clinical trials (1997) (5)
- Microwave thermotherapy for benign prostatic obstruction (2003) (5)
- Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians (2022) (5)
- Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (2021) (5)
- RISK OF BIAS CRITERIA (2013) (5)
- Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders: A Systematic Review (2019) (5)
- Update Alert: Remdesivir for Adults With COVID-19 (2021) (5)
- WITHDRAWN: Cernilton for benign prostatic hyperplasia. (2011) (5)
- Colonoscopy Outcomes by Duration of NPO Status Prior to Colonoscopy with Moderate or Deep Sedation (2015) (5)
- Serum bilirubin and chronic obstructive pulmonary disease (COPD): a systematic review (2021) (5)
- USPSTF erroneously understated life-years-gained benefit of mammographic screening of women in their 40s. (2011) (5)
- Implementing high-value, cost-conscious diabetes mellitus care through the use of low-cost medications and less-intensive glycemic control target. (2012) (5)
- DATA EXTRACTION FORM (2010) (5)
- Effectiveness and harms of mental health treatments in service members and veterans with deployment-related mild traumatic brain injury. (2019) (4)
- PSA screening for prostate cancer (2003) (4)
- WITHDRAWN: Terazosin for benign prostatic hyperplasia. (2011) (4)
- Total Knee Replacement: Summary (2003) (4)
- Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians (2022) (4)
- PEER REVIEW COMMENTS/AUTHOR RESPONSES (2012) (4)
- Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease (2007) (4)
- Implications of the prostate intervention versus observation trial (PIVOT). (2012) (4)
- There is more to life than death. (2012) (4)
- Making Narrative Statements to Describe Treatment Effects (2020) (4)
- The intersection of implementation science and community-based suicide prevention research: Opportunities to advance the field. (2021) (3)
- Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study (2016) (3)
- Clinical Evidence: Non-metastatic prostate cancer. (1999) (3)
- Effectiveness and harms of high-flow nasal oxygen (HFNO) for acute respiratory failure: a systematic review protocol (2020) (3)
- Life Expectancy Calculators (2016) (3)
- WITHDRAWN: Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T I bladder cancer. (2015) (3)
- Excessive Antibiotic Utilization in Men with Prostatitis (2009) (3)
- Screening for prostate cancer. Commentary (2007) (3)
- Improving the Utility of Evidence Synthesis for Decisionmakers in the Face of Insufficient Evidence. (2021) (3)
- Planning controlled clinical trials. Prostatic cancer. (1997) (3)
- Update Alert 2: Remdesivir for Adults With COVID-19 (2021) (3)
- Prostatectomy versus Observation for Early Prostate Cancer. (2017) (3)
- Hemoglobin A1c Targets for Nonpregnant Adults With Type 2 Diabetes Mellitus (2018) (3)
- Screening: simple messages ... sometimes. (2011) (3)
- Rural vs. Urban Ambulatory Health Care (2011) (3)
- Beta-sitosterols for benign prostatic hyperplasia (Review) (2011) (3)
- Chemotherapy for hormone-refractory prostate cancer ( Review ) (3)
- List of Acronyms and Abbreviations (2008) (3)
- Systematic Review: Risk Factors and Interventions to Prevent or Delay Long-term Nursing Home Placement for Adults with Impairments (2019) (3)
- Management of Chronic Insomnia Disorder in Adults (2016) (3)
- Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence (2021) (2)
- Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease (2022) (2)
- A Clinical Practice Guideline Update on the Diagnosis and Management of Stable COPD (2012) (2)
- Chemotherapy for advanced prostate cancer (2005) (2)
- Assessing the Effectiveness of Complex Interventions to Meet the Needs of VA Stakeholders (2019) (2)
- Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update (2022) (2)
- WITHDRAWN: Immunotherapy for advanced renal cell cancer. (2015) (2)
- Cancer of the prostate. (1976) (2)
- Roadmap for Narratively Describing Effects of Interventions in Systematic Reviews (2020) (2)
- 226: Prevalence and Correlates of Prostatitis in a Large Community-Based Cohort of Older Men (2004) (2)
- Table 1, Pharmacologic treatments for Restless Legs Syndrome (2012) (2)
- Meta-analysis of intravesical therapy for superficial bladder cancer: superiority of Bacillus Calmette-Guerin may be confined to high risk patients (2000) (2)
- Population- and Community-Based Interventions to Prevent Suicide. (2022) (2)
- Diagnosis and Treatment of Clinical Alzheimer's-Type Dementia (2020) (2)
- Definitions of Outcomes (2008) (2)
- TREATMENT OF HYPERTENSION IN ADULTS OVER AGE 60 TO HIGHER VS LOWER TARGETS: A CLINICAL PRACTICE GUIDELINE FROM THE AMERICAN COLLEGE OF PHYSICIANS AND THE AMERICAN ACADEMY OF FAMILY PHYSICIANS (2017) (2)
- Inhaled corticosteroids for chronic obstructive pulmonary disease: a status report. (2007) (2)
- Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program. (2022) (2)
- Radical prostatectomy and observation did not differ for mortality in localized prostate cancer (2012) (2)
- Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults (2020) (2)
- Is Gleason 6 cancer? The answer is more than just a ‘name’ (2022) (1)
- In early prostate cancer, radical prostatectomy reduced mortality more than watchful waiting at 23 years (2019) (1)
- Correction: Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer? (2017) (1)
- Treatment of Low Bone Density or Osteoporosis to Prevent Fractures (2021) (1)
- RADICAL PROSTATECTOMY VERSUS OBSERVATION FOR EARLY PROSTATE CANCER: FOLLOW‐UP RESULTS OF THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT): PNFLBA‐11 (2017) (1)
- Reply by Authors (2020) (1)
- The Effect of Medical Scribes in Emergency Departments: A Systematic Review. (2021) (1)
- Chondroitin for osteoarthritis (Protocol) (2009) (1)
- Urologist Practice Styles in the Initial Evaluation of Elderly Men with BPH (2011) (1)
- Management of low risk and low PSA prostate cancer (2014) (1)
- Table 1, Criteria used to classify TBI severity (2012) (1)
- First-line docetaxel chemotherapy for castrate-resistant prostate cancer (2013) (1)
- Screening for prostatic cancer (Protocol) (2004) (1)
- Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (2023) (1)
- Recently Published Studies (2013) (1)
- Purpose of This Report (2016) (1)
- Balancing the benefits and harms of drug treatments for older men with lower urinary tract symptoms (2015) (1)
- The Assessment and Treatment of Individuals with History of Traumatic Brain Injury and Post-Traumatic Stress Disorder (2009) (1)
- Magnetic Resonance Imaging-Based Prostate Cancer Screening: Is High-Value Care Achieved or Does the Holy Grail Remain Elusive? (2018) (1)
- Anticoagulant prophylaxis for hospitalized medical patients. (2007) (1)
- Transitions of Care From Pediatric to Adult Services for Children With Special Healthcare Needs (2022) (1)
- Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy (2018) (1)
- Table 12, Summary of Results from Studies of Dental Pain, Urinary Tract Infection, and Sexually Transmitted Infections (2014) (1)
- Alfuzosin for benign prostatic hyperplasia (2013) (1)
- Figure A, Analytic framework for multidisciplinary postacute rehabilitation for TBI in adults (2012) (1)
- Reactions to Recommendations and Evidence About Prostate Cancer Screening Among White and Black Male Veterans (2021) (1)
- [Non-metastatic prostate carcinoma]. (2001) (1)
- Guidelines on Glycemic Targets for Persons With Type 2 Diabetes. (2018) (1)
- Fecal Microbiota Transplantation for Clostridium Difficile Infection: A Systematic Review of the Evidence (2014) (1)
- Erectile dysfunction. Authors' reply (2006) (1)
- COVID-19 postacute care major organ damage: a systematic review (2022) (1)
- Commentary on: Radical Prostatectomy Versus Observation for Localized Prostate Cancer (2012) (1)
- Treatment for Acute Pain: An Evidence Map (2019) (1)
- Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older (2017) (1)
- Prevalence and correlates of lower extremity arerial disease in hypertensive patient with carotid atherosclerosis: Baseline results from the Multicenter Isradipine/Diuretic Atherosclerosis Study (MIDAS) (1993) (1)
- Similar prostate cancer and all-cause mortality in men with localised prostate cancer undergoing surgery or radiation therapy versus active monitoring at 10 years of follow-up (2017) (1)
- Appendix F. Quality Assessment (2009) (0)
- Appendix F. Table 7, International Restless Legs Study Group Rating Scale (IRLS) scores for iron studies (2012) (0)
- Appendix C, Table 5, Cardiovascular Disease (2011) (0)
- Radical prostatectomy reduced death from prostate cancer but not all cause mortality (2003) (0)
- Appendix G. Table 7, Withdrawals and adverse effects for the dopamine agonist versus levopdopa Part A (2012) (0)
- Table E3, Reported clinical and intermediate outcomes after comparisons of antiviral drugs for chronic hepatitis B (randomized controlled clinical trials) (2008) (0)
- Figure 2, Flow diagram of search strategy (2012) (0)
- Table 7, Outcomes Reported in Studies of Communication Skills Training (2014) (0)
- ACTIVE RESEARCH FINDINGS (2009) (0)
- Table 9, Mean change from baseline for Trail Making B (time in seconds), Carotid artery stenting (CAS) studies. Lower scores indicate a better result (2014) (0)
- Table 5, Overestimation and underestimation of DCIS size by MRI compared with mammography (2009) (0)
- Figure 22, HBV DNA loss at followup off the drug therapies for chronic hepatitis B by patient pretreatment status, baseline HBeAg positivity, and the proportion of the patients with baseline cirrhosis, the results from individual studies (2008) (0)
- Figure 39, Impact of negative margin width on local DCIS or invasive recurrence–multivariate adjusted estimates, pooled with random effects (2009) (0)
- 18 Reducing overdiagnosis in prostate cancer screening and treatment: findings from the us va pivot study and other randomized trials of observation and psa-based monitoring in men with early prostate cancer and implications for improving healthcare value (2019) (0)
- Appendix F. Table 13, Self-rated quality of life and of sleep for iron trials (2012) (0)
- Table 8, Outcomes reported in studies by comparison group (2009) (0)
- [Figure], Figure 12. Remission by matrix level of integration (2008) (0)
- Appendix Figure E1, QUORUM statement data for RCT literature (2009) (0)
- Table 4, Summary of Baseline Characteristics: Biological Skin Equivalents (2012) (0)
- Figure F33, Total local invasive (2009) (0)
- Appendix E Tables and Figures (2008) (0)
- Table 2, Design considerations: What are the short- and long-term comparative effectiveness and harms of treatments for RLS? (2013) (0)
- Table 8, Summary of trial comparators for 10 trials of antibiotic treatment of CDI (2011) (0)
- Table 12, Strength of evidence for the miscellaneous pharmacologic trials (2012) (0)
- Neuropsychological Test Descriptions (2014) (0)
- Table 7, Relative risk of ECG abnormalities in patients with SCI younger vs. older than 65 years of age (2008) (0)
- [Table, Appendix D. Analytic Framework]. (2008) (0)
- Figure 14, Association between duration of oral contraceptive use and DCIS (2009) (0)
- Figure 4, Percent Days Abstinent, Differences between BCT and ICBT: Drug Use Disorder Studies Only (2012) (0)
- Figure 6, Efficacy outcomes for treatment with dopamine agonists: mean change in IRLS rating scale score from baseline (2012) (0)
- Table E9, Evidence tables of the effects of drug interventions on outcomes among patient subgroups (individual RCTs) (2008) (0)
- Figure 23, Association between body composition and DCIS (2009) (0)
- Table F5, Cumulative incidence of DCIS per 100,000 female population in age categories (results from individual studies conducted in different countries sorted by country and age category) (2009) (0)
- Table 12, Association between tumor size and patient outcomes (2009) (0)
- INCIDENCE OF CLINICALLY SIGNIFICANT LOWER URINARY TRACT SYMPTOMS AMONG OLDER MEN (2009) (0)
- [Table, IIEF-5 scoring system]. (2009) (0)
- Appendix G. Table 5, Withdrawals and adverse events for acetohydroxamic acid trials (2012) (0)
- Figure 1, Pathogenesis of CDI (2011) (0)
- Table 2, Prevalence of CVD in adults with SCI (2008) (0)
- Figure 5, Overall incidence of CDI from probiotic primary prevention trials (2011) (0)
- Table 15, Mean change from baseline for Digit Symbol Test, CABG studies. Higher scores indicate a better result (2014) (0)
- FOREST PLOTS FROM POOLED ANALYSES FOR ALCOHOL AND DRUG USE STUDIES (2012) (0)
- Search Strategy for Ongoing Studies (2013) (0)
- Table 23, Mean change from baseline for domains from Altinbas 2011: CAS versus CEA (2014) (0)
- Figure 1, The International Classification of Function, Disability, and Health (ICF) (2012) (0)
- Table F19, Cumulative crude incidence (%) of DCIS among women in the United States (2009) (0)
- Table 9, Clinical outcomes by level of integrated proactive process of care (2008) (0)
- Figure 16, Association between oral contraceptive use and DCIS by starting age (2009) (0)
- [Figure], Figure 9. Mean levels of LDL cholesterol, SCI studies (2008) (0)
- Figure 68, Mean change from baseline in IIEF-EF score (2009) (0)
- Table 6, Confidence Scores for Cardiovascular Disease Studies (2011) (0)
- Table 6, Elements of care process (2008) (0)
- Table 23, Trials from ClinicalTrials.gov and other sources (2011) (0)
- [Figure], Figure 2. Flow chart for Question 1 references (2008) (0)
- Evidence Tables: Renal Colic (2019) (0)
- Appendix D, Table 5, Characteristics of Intensive Care Unit Diagnostic Accuracy Studies (2011) (0)
- Appendix F. Figure 2, Efficacy and Harms data for double-blind dopamine agonist trials (2012) (0)
- [Figure], Figure 11. Treatment response by matrix level of integration (2008) (0)
- Appendix G. Funnel Plots (2009) (0)
- [Table], Evidence Table C5. Intracavernousal Injection Trials (2009) (0)
- Table 5, Confidence Scores for Diabetes and End-Stage Renal Disease Studies (2011) (0)
- Table 4, Effects of drug therapies for chronic hepatitis B on combined outcomes (2008) (0)
- Table 19, Future research recommendations (2011) (0)
- Appendix A. Exact Search Strings (2008) (0)
- Figure 17, Femoral neck – mortality for node 1 internal fixation vs. arthroplasty (2009) (0)
- Table 4, Physical Environment Studies by Patient Outcome Studied (2012) (0)
- Table 27, Influence of architecture on mastectomy effectiveness (2009) (0)
- Table 3, Prevalence of CVD in adults with SCI by age and years after injury (2008) (0)
- Table 7, Evidence for a Moderating Effect of Demographic Factors on Screen Characteristics (2013) (0)
- Quorum Statement and Evidence Tables (2009) (0)
- CRITERIA USED IN QUALITY ASSESSMENT (2013) (0)
- 349 QUALITY AND INTENSITY OF EVALUATIVE CARE ARE ASSOCIATED WITH PROVISION OF BPH SURGERY (2010) (0)
- Figure 1a, Percent Days Abstinent, Differences between BCT and ICBT: Studies Not Conducted with Data from Fals-Stewart (2012) (0)
- Table 3, Significant Risk Factors for Severe Hypoglycemia (2012) (0)
- Executive Summary Table 2a, Overview of Prescribing Outcomes - Antimicrobial Stewardship Interventions for Outpatients (2014) (0)
- Table 21, Summary of case studies/series and potential harms of nonstandard interventions for CDI (2011) (0)
- Appendix Table E1, Observational studies (2009) (0)
- Appendix Table E3, Femoral neck evidence-2 (2009) (0)
- 266 USE OF BPH GUIDELINE RECOMMENDED CARE IN THE MEDICARE POPULATION (2010) (0)
- Mean Change from Baseline Tables (2014) (0)
- Figure 10, Association between menopause and DCIS (2009) (0)
- Table C62, Significant variations in proportion of patients treated with watchful waiting (2008) (0)
- Table 9, Strength of Evidencea (2015) (0)
- EVIDENCE TABLE: OVERVIEW OF STUDIES FOR KEY QUESTIONS 1 AND 2 (2010) (0)
- Table F13, DCIS in different populations at high risk of breast cancer (2009) (0)
- Table 30, Impact of necrosis on the effectiveness of mastectomy vs. breast conserving surgery (2009) (0)
- Figure 19, Improved erection (GEQ-Q1): major depressive disorder in remission (2009) (0)
- Table 2, Number of Studies Reporting Each Outcome (and Study-defined Primary Outcome)a (2015) (0)
- TABLE 1, Details of published studies evaluated in Key Question 1 (2009) (0)
- Table 6, Studies Reporting Management Concordance between Teledermatology and Usual Care (In-Person Dermatology) (KQ2b) (2010) (0)
- [Table, Appendix C. Evidence Tables]. (2008) (0)
- Table 11, Studies Conducted in VA Medical Centers (2014) (0)
- Figure 8, Study Quality of Physical Environment Non-Randomized Studies (2012) (0)
- Use of 5- (cid:1) -Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/ American Urological Association 2008 Clinical Practice Guideline (2009) (0)
- Evidence Tables and Other Supporting Tables and Figures (2012) (0)
- Figure 2, Flow Diagram – Delirium Screening Studies (2011) (0)
- Appendix D, Table 1, Characteristics of Pharmacologic Prevention Studies (2011) (0)
- Table 10, Outcomes Reported in Studies of Rapid Antigen Detection Tests, Polymerase Chain Reaction Assay, and C-Reactive Protein (2014) (0)
- Figure 4, Completion Rate and Adenoma Detection Rate: Outcomes from Observational Studies (2015) (0)
- Figure 2, Analytic framework for CDI diagnostic testing, prevention, and treatment (2011) (0)
- Primary Stone Recurrence Outcomes Tables (2012) (0)
- Table 4, Prevalence and odds of diabetes in adults with SCI, able bodied veterans, and the general population (2008) (0)
- Table 12, Association between lactose intolerance or malabsorption and bone fractures (2010) (0)
- Table 3, Confidence Scores for Preventive Care/Ambulatory Care Sensitive Condition Studies (2011) (0)
- Figure 3, Literature Flow Diagram – Human Resource Practices Studies (2012) (0)
- Point-of-Care Ultrasonography: Clearly More Than a Pretty Picture. (2022) (0)
- Table 1, Population Characteristics of Studies Measuring Hypogonadism in Men with Erectile Dysfunction (2009) (0)
- FOREST PLOTS FOR KEY QUESTION #1 (2012) (0)
- Figure 51, Withdrawals due to adverse events: patients with diabetes (2009) (0)
- Figure 5, Relationship Adjustment using Dyadic Adjustment Scale, Difference in Mean Scores between BCT and ICBT: Alcohol Use Disorder Studies Only (2012) (0)
- Table 5, Study duration and baseline characteristics of patients (means and range) in placebo-controlled studies of dopamine agonists (2012) (0)
- Table 5, Characteristics of integration programs for mental health into primary care (2008) (0)
- Figure 4, Conceptual model for questions 3 and 4 (2009) (0)
- Figure 4, Literature Flow Diagram – Organizational Culture Studies (2012) (0)
- Table 7, Incidence of SLN metastases among patients with an original diagnosis of DCIS* (2009) (0)
- Table 11-1, Principles for addressing common challenges when evaluating genetic tests used as predictive indicators (2012) (0)
- Table 12, Age standardized mortality ratios from CVD in adults with SCI compared to the general population (2008) (0)
- Figure 8, Relationship Adjustment using Dyadic Adjustment Scale, Difference in Mean Scores between BCT and ICBT: Studies with Female Subjects Only (2012) (0)
- Executive Summary Table 1, Overview of Strength of Evidence - Antimicrobial Stewardship Interventions for Outpatients (2014) (0)
- WITHDRAWN: Value of Prostate Cancer Care: New Information on New Therapies Suggest Less is More. (2017) (0)
- Figure 58, Flushing (all cause) (2009) (0)
- [Figure], Figure 10. Off treatment comparative effectiveness of combined therapy with pegylated interferon alfa-2a and lamivudine (results from individual studies and pooled analysis) (2008) (0)
- Figure 12, Intertrochanteric – mortality for node 2 plate/screw comparisons (2009) (0)
- Table 6, Overall strength of evidence for individual outcomes in placebo-controlled studies of dopamine agonists (2012) (0)
- 1632 PREVALENCE OF TREATMENT FOR LOWER URINARY TRACT SYMPTOMS IN COMMUNITY DWELLING OLDER MEN (2010) (0)
- Provider Types and Outcomes in Obstructive Sleep Apnea Case Finding and Treatment (2018) (0)
- Figure 4, Non-adherence to Prescribed Medications, Proportion of Patients (RCTs Only) (2015) (0)
- [Table], Comparison of Mild TBI with Moderate and Severe TBI* (2009) (0)
- Figure 2, Project flow (2013) (0)
- Appendix Table D1, Observational studies of lactose intolerance or malabsorption in association with patient outcomes (2010) (0)
- Table B, Summary of postacute rehabilitation programs studied (2012) (0)
- Table 1, Stakeholder prioritization of research gap questions (2013) (0)
- Figure 12, Short-term harms of treatment with dopamine agonists: any study withdrawal (2012) (0)
- Appendix F. Figure 6, Efficacy and Harms data for double-blind Cabergoline (dopamine agonists) vs. levodopa (2012) (0)
- Prostate cancer (non-metastatic). (2003) (0)
- 17 The role of american college of physicians clinical guidelines on improving healthcare value and reducing harms of overdiagnosis and overtreatment: example from breast and colorectal cancer screening (2019) (0)
- Appendix F. Table 6, International Restless Legs Study Group Rating (IRLS) scores for nonpharmacologic studies (2012) (0)
- Figure 4, Flow Diagram – Delirium ICU Diagnosis Studies (2011) (0)
- Figure 25, Association between DCIS and common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer (odds ratios from the multinational case-control study, adjusted to age and other variables) (2009) (0)
- Table E10, Summary tables of the effects of therapies for CHB in patient subpopulations by baseline status of chronic hepatitis B (2008) (0)
- Table 2, Cardiovascular events in adults with chronic traumatic SCI (2008) (0)
- Table 4, Prevalence of CVD* according to SCI neurological category (2008) (0)
- Listing of Excluded Studies—Cancer Population (2004) (0)
- COMMON METHODOLOGICAL ERRORS AND RECOMMENDATIONS FOR FUTURE CLINICAL TRIALS OF WOUND HEALING (2012) (0)
- Figure 6, Study Quality of Human Resource Practices Non-Randomized Studies (2012) (0)
- Table F14, Association between family history, genetic predisposition, and DCIS (2009) (0)
- Figure 13, Short-term harms of treatment with dopamine agonists: study withdrawals due to adverse events (2012) (0)
- Table 6, Clinical outcomes after different treatments in patients with localized prostate cancer (2008) (0)
- Table 3, Organizational Culture Studies by Practice Studied and Patient Outcome Studied (2012) (0)
- Appendix F. Data Abstraction Form (2008) (0)
- Table 35, Summary evidence map: All cancer events, overall and breast cancer mortality, and adverse events across treatments (2009) (0)
- DECISION QUALITY AND DECISION IMPACT MEASURE PATTERNS IN INCLUDED STUDIES (2014) (0)
- Figure 32, Time trend in crude annual incidence of DCIS per 1,000 mammograms from January 1997 to December 2003 in women ages 50–69 years (results from Breast Cancer Surveillance Consortium mammography registries) (2009) (0)
- Table 23, Association between treatment options for DCIS and patient outcomes from RCTs by trial (2009) (0)
- Appendix Table E4, Intertrochanteric evidence-1 (2009) (0)
- Table F36, Outcomes after mastectomy compared to lumpectomy plus radiation in women with DCIS (observational studies) (2009) (0)
- [Figure], Figure 11. Mean levels of triglycerides, SCI studies (2008) (0)
- Table 13, Association between low lactose diets, lactose intolerance or malabsorption, and osteoporosis (2010) (0)
- Baseline Characteristics Summary Tables (2012) (0)
- Venous Thromboembolism Prophylaxis (2012) (0)
- Appendix F. Table 10a, Self-rated quality of sleep for alpha-2-delta ligands trials: Medical Outcomes Scale- Sleep Problems Index II or Pittsburgh Sleep Quality Index (2012) (0)
- Appendix C, Table 9, Use of Medication (2011) (0)
- Figure 19, Unstable intertrochanteric – mortality for node 1 plate/screw vs. intramedullary nail (2009) (0)
- Figure 7, Femoral neck decision tree/literature map (2009) (0)
- Table 12, Mean change from baseline for Grooved Pegboard Test (seconds), Carotid artery stenting (CAS) studies. Lower scores indicate a better result (2014) (0)
- Figure 19, Association between types of DCIS and age at first live birth compared to 20–24 years (Danish Breast Cancer Registry) (2009) (0)
- Table 17, Other outcomes (# subjects / # assessed) for vancomycin versus metronidazole (2011) (0)
- Appendix G. Table 10, Withdrawals and adverse effects for the iron trials (secondary RLS) (2012) (0)
- Figure 1, Literature Flow (2013) (0)
- Table 1, Factors associated with increased risk of selected outcomes in adults with chronic hepatitis B (2008) (0)
- Table 19, Nonstandard intervention for treatment of initial and recurrent CDI (2011) (0)
- Table 16, Association between necrosis and patient outcomes (2009) (0)
- Table 4, Components of Multi-Component Interventions for Delirium Prevention (2011) (0)
- Supporting Tables and Figures: Silodosin (2016) (0)
- Table F11, Association between body composition and DCIS (2009) (0)
- Table 5, Mean change from baseline for Rey Auditory Verbal Learning Test (number of words), CABG studies. Higher scores indicate a better result (2014) (0)
- Appendix F. Figure 5, Efficacy and Harms data for double-blind Iron therapy trials (2012) (0)
- Figure 30, Improved erection (GEQ-Q1) (2009) (0)
- Table 8, Clinical outcomes by level of provider integration (2008) (0)
- Appendix F. Analytic Framework (2007) (0)
- [Figure], Figure 18. Adjusted odds ratio of CVD in patients with SCI: Tetraplegia with no functional motor preservation compared to paraplegia and no functional motor preservation (2008) (0)
- Figure 11, Proportion of ulcers healed – Electromagnetic Therapy versus Sham (2012) (0)
- Table 20, Association between HER status and local DCIS or invasive carcinoma (2009) (0)
- Table 22, Summary of characteristics of included RCTs (2009) (0)
- Table 13, Intracavernosal Injection: Improvement in Erections* (2009) (0)
- Figure 49, Dyspepsia (all cause) (2009) (0)
- [Figure], Figure 9. Remission rate by level of integrated process of care (2008) (0)
- Flower Pollen Extract and its Effect on the Prostate Phytotherapy for benign prostatic hyperplasia (2017) (0)
- Table 1, Patient characteristics in studies that reported cardiovascular events in adults with SCI (2008) (0)
- Figure 10, Efficacy outcomes for treatment with alpha-2-delta ligands: proportion of patients who reported improved or much improved on the clinician-rated global impressions scale (CGI) (2012) (0)
- Table 1, Human Resource Practices Studies by HR Practice Studied and Patient Outcome Studied (2012) (0)
- Table 1, Prevalence of occult DCIS in autopsy studies (2009) (0)
- Figure 5, Literature Flow Diagram – Physical Environment Studies (2012) (0)
- PEER REVIEW COMMENTS AND AUTHOR RESPONSES (2011) (0)
- Table F2, Original epidemiologic studies of risk factors for DCIS (2009) (0)
- [Figure], Figure 1. Classic phases in chronic Hepatitis B infection (HBeAg-positive) (2008) (0)
- Figure 7, Efficacy outcomes for treatment with dopamine agonists: change in RLS-specific quality of life (2012) (0)
- [Figure], Figure 3. Flow chart for Question 2 references (2008) (0)
- Figure 11-2, Generic analytic framework for evaluating predictive genetic tests when the impact on family members is important (2012) (0)
- [Table, PEER REVIEW COMMENTS/AUTHOR RESPONSES]. (2012) (0)
- Table 8, Goal Attainment - Polypharmacy/High Risk (3 studies) (2015) (0)
- Appendix C, Table 8, Mental Health (2011) (0)
- [Table, Ongoing Trials]. (2013) (0)
- Table 3, Level of integration of providers (2008) (0)
- Figure 4b, Primary Diagnostic Accuracy of Store and Forward Studies (2010) (0)
- [Figure], Figure 13. HDL cholesterol levels of able-bodied males by age (NHANES) (2008) (0)
- Table 8, Population Characteristics of Studies Measuring Serum LH/FSH Levels in Men with Erectile Dysfunction (2009) (0)
- Table 2, Summary of key points and recommendations for quantitative synthesis in Comparative Effectiveness Reviews (2010) (0)
- Table 16, All-cause mortality (# subjects / # randomized) for all other standard treatment trials (2011) (0)
- Efficacy and safety of laser prostatectomy techniques for treating symptomatic benign prostatic hyperplasia (2001) (0)
- In localized prostate cancer, active monitoring, prostatectomy, and radiotherapy did not differ for 10-y cancer deaths (2016) (0)
- Table 15, Sustainability of community integration questionnaire score (2012) (0)
- Table 3, Screens Used to Identify PTSD in Primary Care Clinics (2013) (0)
- 21: Age Related Variation in Health Care Utilization for Erectile Dysfunction before and after the Introduction of Oral Pharmacotherapy (2005) (0)
- [Figure], Figure 6. Off treatment effectiveness of reverse transcriptase inhibitors compared to placebo (results from individual studies and pooled analysis with random effects model) (2008) (0)
- Figure 13, Association between oral contraceptives and DCIS (2009) (0)
- Figure 2, Analytic framework from “Future Research Needs to Reduce the Risk of Primary Breast Cancer in Women” (2012) (0)
- Executive Summary Table 1, Summary of Outcomes Reported in Included Studies (2015) (0)
- Cryotherapy for localised prostate cancer (Review) (2012) (0)
- Table 1, Overview of Therapies for Diabetic Ulcers (2012) (0)
- Future Research Recommendations (2012) (0)
- Table 16, Barriers to integrating primary care and mental health care (2008) (0)
- FOREST PLOTS FOR STRENGTH OF EVIDENCE ANALYSIS (2014) (0)
- PEER REVIEW COMENTS/AUTHOR RESPONSES (2012) (0)
- Table 17, Association between predicted Van Nuys Index risk categories and patient outcomes (results from observational studies) (2009) (0)
- FecalMicrobiota Transplantation for Clostridiumdifficile Infection A Systematic Review (2015) (0)
- Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia : A Systematic Review and Meta-analysis (2017) (0)
- Invitation to Key Informants (2016) (0)
- Table 3, Prevalence of Hypogonadism in Men with Erectile Dysfunction (serum free or calculated testosterone) (2009) (0)
- Table 2, Summary of Baseline Characteristics: Collagen (2012) (0)
- Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications (2012) (0)
- Table E6, Levels of viral load, biochemical, or histologic outcomes after antiviral drugs in adults with chronic hepatitis B (2008) (0)
- Figure 3, Quality of Live Interactive Studies (N=8) (2010) (0)
- Figure 16, Femoral neck – mortality for node 1 internal fixation vs. total hip replacement (2009) (0)
- Table 1, Empirically Supported Couple and Family Treatments for Mental Health Conditions (Baucom 1998) (2012) (0)
- Table 12-1, General PICOTS typology for review of prognostic tests (2012) (0)
- PRACTICE PATTERNS IN BPH SURGICAL THERAPY IN THE U.S.—THE DRAMATIC INCREASE IN THE APPLICATION OF MINIMALLY INVASIVE TECHNOLOGIES (2008) (0)
- [Table], Evidence Table C7. Intra-urethral Suppositories (2009) (0)
- Description and Characteristics of Included Studies (2016) (0)
- Figure 11-3, Analytic framework for evidence gathering on CYP450 genotype testing for SSRI treatment of depression (2012) (0)
- [Table], Evidence Table F4. Apomorphine (sublingual) (2009) (0)
- Table 5, Summary of Baseline Characteristics: Platelet-Derived Growth Factor (2012) (0)
- Table F1, Incidence of DCIS in population based studies (2009) (0)
- Table 11, Adjusted relative effect of margin on patient outcomes (2009) (0)
- [Table], Evidence Table C9. Testosterone Treatment of ED (2009) (0)
- Figure 37, Contralateral breast cancer with time since DCIS diagnosis (2009) (0)
- [Table], Evidence Table C6. Subcutaneous Treatment Trials (2009) (0)
- Figure 2, Conceptual model for question 1 (2009) (0)
- Table 24, Events reduced by treating 1,000 people with radiation after breast conserving therapy (statistically significant effects only) (2009) (0)
- Appendix D. Reference List of Excluded Studies (2009) (0)
- Figure 44, Any adverse events (all cause) (2009) (0)
- [Table], Family Interventions since 1996 that Improve Outcomes for US Patients with Mental Health (MH) Conditions (2012) (0)
- Figure 7, Percent Days Abstinent, Differences between BCT and ICBT: Studies with Female Subjects Only (2012) (0)
- Figure 8, Age-adjusted rates of DCIS and invasive breast cancer, SEER 2002–2006, by race (2009) (0)
- Table E5, Summary tables of the effects of drug therapies for chronic hepatitis B on outcomes (2008) (0)
- Figure 25, Successful intercourse attempts: patients with hypertension taking anti-hypertensivedrugs (2009) (0)
- Appendix Table E12, Intertrochanteric - continuous functional/pain outcomes from studies with extractable data (2009) (0)
- Appendix C, Table 2, Cancer Screening (2011) (0)
- Table 2, Overview of Outcomes Reported (2015) (0)
- Appendix G. Table 9, Specific adverse effects for the dopamine agonist versus levodopa Part C (2012) (0)
- Figure 41, Improved erection (GAQ-Q1) (2009) (0)
- Figure 1, Literature Flow Chart (2015) (0)
- Figure 2, Analytic framework (2012) (0)
- Appendix I. Table 3, Cognitive Outcomes Tables: Incident Cognitive Impairment Defined by Composite of Neuropsychological Tests – CAS and CEA (2014) (0)
- Table 5, Relative risk of ECG abnormalities in adults with SCI compared to able-bodied controls (2008) (0)
- Table 3, Studies Reporting Diagnostic Accuracy using Histopathology/Lab Tests as Gold Standard (KQ1a) (See Appendix D for abbreviations) (2010) (0)
- Appendix Table E2, Femoral neck evidence-1 (2009) (0)
- Figure 27, Association between alcohol and dietary factors and DCIS (2009) (0)
- Figure 14, The mean IIEF-Q3 score: Type I-II diabetes (2009) (0)
- 499 UROLOGIST INTENSITY IN THE INITIAL EVALUATION OF ELDERLY MEN WITH BPH (2010) (0)
- [Figure], Figure 1. Characteristics of Integration Linked to Process of Care (2008) (0)
- Table 6, Goal Attainment - Dyslipidemia (7 studies) (2015) (0)
- Appendix F. Table 5, International Restless Legs Study Group Rating (IRLS) scores for miscellaneous pharmacologic studies (2012) (0)
- Appendix D, Table 3, Characteristics of Non-Pharmacologic or Mixed Treatments Prevention Studies (2011) (0)
- Does Tiotropium Reduce Hospitalizations in Chronic Obstructive Pulmonary Disease (2008) (0)
- Figure 5, The mean IIEF-Q4 score (2009) (0)
- STUDY QUALITY TABLES (2012) (0)
- Figure 12, Association between hormone replacement therapy and DCIS (2009) (0)
- Evidence Tables: Acute Migraine (2019) (0)
- Table 4, Level of integrated proactive process of care (2008) (0)
- Study Quality/Risk of Bias Tables (2012) (0)
- Table E14, Other baseline factors as predictors of outcomes, and other outcomes (n=3) (2008) (0)
- Table 3, Toxin gene detection tests compared to immunoassays (2011) (0)
- Table 1, Gold Standard Structured Diagnostic Interviews for Diagnosing PTSD (2013) (0)
- Literary Functional Equivalence : Some Case Studies (2004) (0)
- Figure 1, Reference Flow Chart (2010) (0)
- Table 3, Design considerations: Does tolerance/effectiveness of treatment for RLS vary by demographic/clinical/genetic factors? (2013) (0)
- Table 13, Overview of secondary outcomes results (2012) (0)
- Search Strategy for Recently Published Studies (2013) (0)
- Figure 34, Cumulative incidence of DCIS by tumor grade and size in Australia (New South Wales Central Cancer Registry, per 100,000 women age standardized to the world population from 1995–2000) (2009) (0)
- [Figure], Figure 19. Hazard ratio of dying based on ECG abnormality vs. normal ECG among VA users with SCI and able-bodied VA users (2008) (0)
- Appendix C, Table 11, Medical Appointments with Providers (2011) (0)
- Table 3, Summary of Baseline Characteristics: Biological Dressings (2012) (0)
- Table E12, Summary of study IDs meeting eligibility for question 4 (2008) (0)
- Table 15, Summary of Baseline Characteristics: Silver Products (2012) (0)
- Table 6, Design considerations: Is RLS a risk factor for cardiovascular disease and other health conditions/outcomes? (2013) (0)
- [Figure], Figure 8. Mean levels of total cholesterol, SCI studies (2008) (0)
- Fish Oil Supplementation Does Not Lower Plasma Cholesterol in Men with Hypercholesterolemia (2020) (0)
- Supporting Tables: Efficacy of Psychological Interventions for Insomnia Disorder (2015) (0)
- Appendix Table D2, Association between low dairy Ca++ intake and bone fractures (2010) (0)
- Table F30, Total regional recurrence (2009) (0)
- Table 10, Strength of evidence for productivity outcomes (2012) (0)
- Table F37, Outcomes after mastectomy from observational studies that did not report events and combined treatment options (2009) (0)
- Table F22, BRCA-associated DCIS detected with MIR screening in prospective case-series (modified from Hagen, 2007) (2009) (0)
- Figure 9, HBsAg loss combined with other criteria of resolved hepatitis B at followup off the therapy (results from individual RCTs) (2008) (0)
- LOWER URINARY TRACT SYMPTOMS AND RISK OF FALLS IN OLDER MEN (2008) (0)
- Table 23, Testosterone: Improvement in Sexual Intercourse Outcomes (2009) (0)
- Figure 5, Clinical Outcomes for Depression Trials (2015) (0)
- Table 16, Subcutaneous Injection: Patients with Adverse Events (2009) (0)
- [Figure], Figure 8. Treatment response by level of integrated process of care (2008) (0)
- Table 7, Summary of risk factors for CDI (2011) (0)
- Hyperplasia : A Systematic Review Saw Palmetto Extracts for Treatment of Benign Prostatic (2000) (0)
- Figure 3, Association between milk intake and history of any fracture (2010) (0)
- Table 18, Intra-urethral Treatment: Improvement in Erections* (2009) (0)
- Figure 24, Improved erection (GEQ-Q1): patients with hypertension taking anti-hypertensive drugs (2009) (0)
- Figure 21, Association between breast density, previous history of breast biopsy or surgery, and DCIS (2009) (0)
- Figure 14, Significant effects on HBeAg seroconversion for chronic hepatitis B (significant risk differences from individual RCTs and pooled with random effects model) (2008) (0)
- Figure 38, Crude odds of local DCIS or invasive carcinoma by margin status in women with DCIS (2009) (0)
- Tamsulosin for treatment of symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects (2001) (0)
- Table 7, Odds ratios of diabetes or CVD in adults with SCI compared to able bodied (2008) (0)
- Figure 9, Headache (all cause) (2009) (0)
- Figure 21, The mean IIEF-Q4 score: major depressive disorder in remission (2009) (0)
- Appendix C, Table 13, Provider Availability and Expertise (2011) (0)
- Table 3, Excerpt from “Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Treating Hypertension” (2012) (0)
- Table 17, Strength of Evidence – Advanced Wound Care Therapies for Venous Ulcers (2012) (0)
- Table 20, Alprostadil (Topical Cream) vs. Placebo: Sexual Encounter Profile (SEP) (2009) (0)
- [Table], Evidence Table C8. Topical Treatments of ED (2009) (0)
- Table A1, Treatments for chronic urinary retention (2014) (0)
- [Figure], Figure 13. Methods for paying for care management (from Bachman et al., 2006) (2008) (0)
- Appendix F. Table 3, International Restless Legs Study Group Rating Scale (IRLS) scores for alpha-2-delta ligands studies (2012) (0)
- Table F127, Effects of vaginal tapes and sling procedures on improvement of urinary incontinence in women (events) (table is sorted by rate of improvement after active treatment, from highest to lowest) (2007) (0)
- Appendix F. Table 2, International Restless Legs Study Group Rating Scale (IRLS) scores for the dopamine agonist studies (2012) (0)
- Table 26, Testosterone Treatment: Patients with Adverse Events (2009) (0)
- Figure 7, Comparative effectiveness of active treatments on HBsAg loss at the end of the treatments (results from individual RCTs) (2008) (0)
- Figure 5, Proportion of Diabetic Ulcers Healed – Silver Products (2012) (0)
- Table F6, Age-adjusted cumulative incidence of DCIS among race subgroups per 100,000 U.S. female population (results from individual studies conducted in the United States are sorted by race subgroup and the year of the events) (2009) (0)
- Table 4, Prevention interventions (2011) (0)
- Comparative effectiveness research in clinical practice. (2014) (0)
- [Figure], Figure 10. Symptom severity by matrix level of integration (2008) (0)
- Table 9, Hazard ratio of dying having ECG abnormality vs. normal ECG among patients with SCI and able-bodied veterans (2008) (0)
- Figure 7, Incidence of DCIS and invasive breast cancer by age (2002–2006) (2009) (0)
- Figure 19, ALT normalization at followup off the drug therapies for chronic hepatitis B (significant risk differences from individual RCTs and pooled with random effects model) (2008) (0)
- Table 5, Outcomes Reported in Studies of Guidelines (2014) (0)
- TECHNICAL EXPERT PANEL MEMBERS (2012) (0)
- Figure 9, Femoral neck - mortality for node 3 unipolar vs. bipolar hemiarthroplasty (2009) (0)
- [Figure], Figure 4. Off treatment effectiveness of monotherapy with interferon compared to no treatment (results from individual studies and pooled analysis with random effects model) (2008) (0)
- Table 13, Association between tumor grade and patient outcomes (2009) (0)
- Figure 3, Percent Days Heavy Drinking, Differences between BCT and ICBT: Alcohol Use Disorder Studies Only (2012) (0)
- Table 7, Effects of antiviral drugs on HBeAg-negative patients (relative risk from individual RCTs) (2008) (0)
- Table F40, Observational studies of control and systemic outcomes stratified by lumpectomy alone (2009) (0)
- Figure 7, Association between genetic polymorphism TT vs. C/C and positive tests for lactose malabsorption, crude odds ratios from two Austrian observational population based studies of genetic screening for osteoporosis (2010) (0)
- Table F12, Incidence of DCIS among women with familial risk in breast cancer surveillance trials (modified from Brekelmans, 2001) (2009) (0)
- Flower Pollen Extract and its Effect on the Prostate A systematic review of Cernilton for the treatment of benign prostatic hyperplasia (2017) (0)
- Table 6, Subjects withdrawing from treatment and experiencing adverse events from randomized controlled trials (2008) (0)
- Table 10, Clinical outcomes by mental illness (2008) (0)
- Figure 26, Age adjusted odds ratio of DCIS among categories of sex hormones (from the New York University Women’s Health Study) (2009) (0)
- Early Detection and Treatment of Prostate Cancer (2000) (0)
- Table 19, Association between progesterone receptor (PR) status and outcomes (2009) (0)
- Figure 18, Intertrochanteric – mortality for node 1 plate/screw vs. intramedullary nail (2009) (0)
- Table F10, Association between parity and DCIS (2009) (0)
- Table 10, Age standardized mortality ratios in adults with chronic SCI compared to the general population (no adjustment for other confounding factors) (2008) (0)
- Journal Introduces Cochrane Reviews (2010) (0)
- Table 9, Confidence Scores for Mental Health Studies (2011) (0)
- Figure 10, Flushing (all cause) (2009) (0)
- Table 1, Prevalence of metabolic syndromes, diabetes, glucose, lipid abnormalities, and BMI in adults with chronic posttraumatic SCI (2008) (0)
- Figure 5, Association between milk intake and osteoporotic bone fractures (2010) (0)
- Figure 6b, Aggregated Diagnostic Accuracy of Store and Forward Studies (2010) (0)
- Figure 13, Symptomatic response# of adult lactose malabsorbers to lactose ingested without nutrients other than milk (2010) (0)
- Table 1, Studies examining variation in outcomes associated with variation in access (KQ1) (2011) (0)
- Appendix. F. Figure 3, Efficacy and Harms data for double-blind alpha-2-delta ligands trials (2012) (0)
- Table 2, Summary of studies on wheeled mobility service delivery (2012) (0)
- Table 11, Functional and quality of life outcomes (2008) (0)
- Figure 2, Percent Days Abstinent, Differences between BCT and ICBT: Alcohol Use Disorder Studies Only (2012) (0)
- Table 14, Association between architecture and patient outcomes (2009) (0)
- [Figure], Figure 5. Off treatment effectiveness of combined therapy with interferon compared to placebo (results from individual studies and pooled analysis with random effects model) (2008) (0)
- Improving GRADE evidence tables part 4: a three-arm non-inferiority randomized trial demonstrates improved understanding of content in summary of findings tables with a new format. (2022) (0)
- Table E4, Evidence tables of the effects of antiviral drugs on patient outcomes (individual randomized controlled clinical trials) (2008) (0)
- Fish oil supplements do not treat hypercholesterolemia in middle-aged men (1991) (0)
- Figure 17, Association between DCIS and age at first live birth compared to less than 20 years (2009) (0)
- Figure 8, Pertrochanteric decision tree/literature map (2009) (0)
- Table 7, Confidence Scores for HIV/AIDS Studies (2011) (0)
- Previously Published Systematic Reviews and Meta-analysis (2009) (0)
- Table 24, Testosterone (T) Combined with PDE-5 inhibitors: Improvement in Sexual Intercourse Outcomes (2009) (0)
- STUDY SELECTION FORM (2011) (0)
- Figure 12, Improved erection (GEQ-Q1): Type I-II diabetes (2009) (0)
- Table 18, Summary of study characteristics for blinded LI treatment studies (2010) (0)
- Figure 60, Absolute mean change in IIEF-EF score (2009) (0)
- Table 4, Design considerations: What geographic/environmental factors are associated with RLS? (2013) (0)
- Appendix Table D6, Association between lactose intake and metabolism and bone mineral density (BMD, g/cm2) (2010) (0)
- Table 14, Sustainability of productivity outcomes (2012) (0)
- MP-20.20: BPH surgical treatment trends in the U.S. – the dramatic increase in the application of minimally invasive technologies (2007) (0)
- Figure 14, Percentage of subjects reporting abdominal pain (2010) (0)
- Appendix F. Table 8, IRLS Remitters (score = 0): Absolute effect per 100 patients (2012) (0)
- Appendix F. Table 11, Self-rated quality of life and of quality sleep for the miscellaneous pharmacologic trials (2012) (0)
- Table 12-3, Example of a reclassification table based on predicted outcome probabilities (2012) (0)
- Figure 13, Significant relative risk of virological, histological and biochemical outcomes after drug therapies for chronic hepatitis B (results from individual RCT and pooled consistent results using random effects model) (2008) (0)
- Table F27, Total all mortality (2009) (0)
- Supporting Tables: Efficacy of Pharmacologic Interventions for Chronic Insomnia (2015) (0)
- Appendix F. Table 9a, Self-rated quality of sleep for dopamine agonist trials: Medical Outcomes Scale- Sleep Problems Index II (2012) (0)
- Appendix F: Conceptual Definition of Outcomes (2008) (0)
- Appendix C, Table 6, HIV/AIDS (2011) (0)
- Appendix D: Patient Inclusion and Exclusion Criteria (2008) (0)
- DECREASED REIMBURSEMENT FOR ANDROGEN SUPPRESSION THERAPY DOES NOT LEAD TO WITHDRAWL OF CARE IN METASTATIC PROSTATE CANCER (2009) (0)
- Appendix C, Table 4, Diabetes/End Stage Renal Disease (ESRD) (2011) (0)
- Appendix Table E10, Femoral neck mortality (2009) (0)
- Executive Summary Table 2, Strength of Evidence - Advanced Wound Care Therapies for Venous Ulcers (2012) (0)
- Table 13, Baseline Study Characteristics: Biological Skin Equivalents (2012) (0)
- Figure 6, Time to Complete Healing, Diabetic Ulcers – Negative Pressure Wound Therapy (2012) (0)
- Table A, Summary of evidence (2009) (0)
- Table 9, Time to Treatment and Clinic Dermatology Visits Avoided for Teledermatology Studies (KQ3) (2010) (0)
- Table 10, Initial clinical cure (# subjects / # randomized) for all other standard treatment trials (2011) (0)
- Table 2, Calcium content in common foods (2010) (0)
- Table 10, Overall strength of evidence for individual outcomes in placebo-controlled studies of alpha-2-delta ligands (2012) (0)
- Appendix D. Analytic Framework (2008) (0)
- [Figure], Figure 8. Off treatment comparative effectiveness of combined with interferon or reverse transcriptase inhibitors (results from individual studies and pooled analysis with random effects model) (2008) (0)
- Figure 65, Improved erection (GAQ-Q) (2009) (0)
- Table F15, Association between blood levels of lipids, proteins, sex hormones, and mitogenes with DCIS (2009) (0)
- [Table], Evidence Table C1. Oral Sildenafil (2009) (0)
- Appendix Table D5, Gains in osteodensitometric values in prepubertal boys consuming low lactose diet (74% of the recommended daily Ca++ intake) after interventions with dairy foods (1,607 vs. 747mg/day of Ca++) (2010) (0)
- Prostate cancer: non-metastatic. (2002) (0)
- Supporting Tables: Efficacy of Complementary and Alternative Medicine Interventions for Insomnia Disorder (2015) (0)
- [Figure], Figure 7. Weighted mean differences in lipid levels (mg/dL): Spinal cord injured subjects vs. controls (2008) (0)
- Table 8, Outcomes Reported in Studies of Restriction Policies (2014) (0)
- PROSTATE CANCER : EMERGING CONCEPTS. AUTHORS' REPLY (1996) (0)
- Table 15, Patient subgroup/comorbidity concerns (2008) (0)
- Technical Expert Panel Members and Affiliation (2011) (0)
- Table 4, Sensitivity and specificity of breast MRI for detecting multicentric disease (2009) (0)
- Table 13, Strength of evidence for the nonpharmacologic trials (2012) (0)
- Table 16, Strength of evidence for sustainability outcomes (2012) (0)
- Table 14, Baseline Study Characteristics: Keratinocytes (2012) (0)
- Table 14, Strength of evidence for iron trials for the treatment of secondary RLS (2012) (0)
- Table 9, Initial clinical cure (# subjects / # randomized) for vancomycin versus metronidazole (2011) (0)
- Risk-of-Bias Assessment Form for Observational Studies (2016) (0)
- [Figure], Figure 3. Survival by hepatitis status, modified from Tong, 2006 (2008) (0)
- Figure 7, Proportion of Diabetic Ulcers Healed – Hyperbaric Oxygen Therapy (2012) (0)
- Appendix E. Additional Acknowledgments (2009) (0)
- [Figure], Figure 5. Treatment response by level of provider integration (2008) (0)
- Table 2, Summary of Study Characteristics for Teledermatology Studies (KQ1 and KQ2) (2010) (0)
- [Figure], Figure 9. Off treatment comparative effectiveness of monotherapy with pegylated interferon alfa-2a compared to lamivudine (results from individual studies and pooled analysis) (2008) (0)
- Stroke/TIA Outcomes Tables (2014) (0)
- Table 1, Recommended calcium intake by age group (2010) (0)
- Figure 5, Study Flow (2009) (0)
- Effects of Nurse Staffing on Resident Outcomes in Nursing Homes: A Systematic Review. (2022) (0)
- Table 6, Summary of Baseline Characteristics: Platelet Rich Plasma (2012) (0)
- Table F18, Association between nonsteroidal anti-inflammatory agents and DCIS (2009) (0)
- Table 6, Proportion of patients with MRI-detected contralateral breast cancer (2009) (0)
- Figure 20, Combined outcomes at the end of the treatments by baseline ALT levels (individual RCTs) (2008) (0)
- Appendix G. Table 3, Specific adverse effects for the dopamine agonist trials Part C (2012) (0)
- Table 2, Studies examining the efficacy of interventions designed to increase access for veterans (KQ2) (2011) (0)
- Table 26, Impact of necrosis on the effectiveness of lumpectomy plus radiation vs. lumpectomy alone (2009) (0)
- [Figure], Figure 15. Prevalence of BMI levels by age group (NHANES 1999-2002) (2008) (0)
- Table 10, Confidence Scores for Processes or Structure of Care Studies (2011) (0)
- Table 14, Description of exercise intervention studies with lipid or cardiovascular related outcomes in people with SCI (2008) (0)
- Table 13, Financial/economic outcomes (2008) (0)
- Table D1, Operational definitions of treatment options for hepatitis B (2008) (0)
- Table 1, Example of a qualitative summary of studies with no events in both groups (2010) (0)
- [Table, IIEF domains and the scoring]. (2009) (0)
- Figure 2, Proportion of Diabetic Ulcers Healed - Biological Skin Equivalent (Dermagraft) versus Standard Care (2012) (0)
- Table 19, Occurrence of GI symptoms in randomized trials (2010) (0)
- Figure 32, Flushing (all cause) (2009) (0)
- Figure 17, Any adverse events (treatment-related): Type II diabetes (2009) (0)
- Surgery versus radiotherapy for muscle invasive bladder cancer. (2002) (0)
- Table 5, Design considerations: What genetic linkages/biomarkers are associative, diagnostic of, or causally define RLS? (2013) (0)
- Figure 3, Efficacy outcomes for treatment with dopamine agonists: proportion of study participants who reported greater than 50 percent reduction in mean IRLS score from baseline (2012) (0)
- Table 1, Potential issues for methodological future research needs (2012) (0)
- Table F17, Association between behavioral risk factors and DCIS (2009) (0)
- Figure 55, Serious adverse events (all cause) (2009) (0)
- Figure 2, Reference flow diagram (2010) (0)
- Figure 4, Comparative effectiveness of active drugs on clinical outcomes, results from individual RCTs (2008) (0)
- Table 2, Diagnostic Accuracy Terms Used in this Report (2013) (0)
- Figure A, Analytic framework (2013) (0)
- Figure 21, The effects of lamivudine, 100mg/day compared to placebo at the end of the treatment depending on baseline ALT level (4 lamivudine-controlled Phase III trials) (2008) (0)
- Table 10, Incidence of SLN metastases according to AJCC staging system (2009) (0)
- Table 9, Summary of Baseline Characteristic: Hyperbaric Oxygen Therapy versus Standard Care/Sham (2012) (0)
- Appendix G. Table 5, Adverse effects for the alpha-2-delta ligands trials Part B (2012) (0)
- [Figure], Figure 7. Symptom severity outcomes by level of integrated process of care (2008) (0)
- Figure 17, Patients with ≥1 adverse effect, alpha-2-delta ligands trials (2012) (0)
- Table 2, Population-based screening trials (2009) (0)
- Appendix F. Table 14, Patient global impressions responders (PGI) at end of treatment for dopamine agonist studies (2012) (0)
- Table 1, Definitions of clinically integrated health care (2008) (0)
- RESEARCH HIGHLIGHTS: EBM from the Cochrane Library (2009) (0)
- PEER REVIEW COMMENTS AND RESPONSES (2011) (0)
- [Table], Evidence Table C3. Oral Tadalafil (2009) (0)
- Figure 8, Any adverse events (treatment-related) (2009) (0)
- Table 5, (A) Studies of multiple interventions used together to reduce CDI incidence (2011) (0)
- Table 5, Screen Performance Characteristics (2013) (0)
- Literary Functional Equivalence (2004) (0)
- Evidence Tables: Fractures (2019) (0)
- Figure 2, Effects of interferon alfa-2b and reverse transcriptase inhibitors on clinical outcomes compared to placebo or no active treatment—Relative risk from four individual RCTs (2008) (0)
- COCHRANE COLUMN Screening for prostate cancer (2007) (0)
- Presentation of Future Research Needs (2012) (0)
- Figure 14, Femoral neck – mortality for node 2 hemi vs. total hip replacement (2009) (0)
- Figure C11, Which therapy offers the best survival to patients with clinically localized prostate cancer? Treatment recommendations by urologists and radiation oncologists (Fowler, 2000) (2008) (0)
- STUDY SELECTION AND DATA EXTRACTION FORM (2013) (0)
- Table 22, Summary of evidence (2011) (0)
- Figure 40, Successful intercourse attempts (SEP-Q3) (2009) (0)
- Table 9, Summary of study baseline characteristics for alpha-2-delta ligand drugs trials (2012) (0)
- Cognitive Outcomes Tables: Clinically Diagnosed Cognitive Impairment (2014) (0)
- Table 5, Overview of included studies (2012) (0)
- Table 9, Summary of evidence (2009) (0)
- Table 16, Ulcer Size, Ulcer Duration, and Definitions of Closure: Electromagnetic Therapy (2012) (0)
- Table 6, Relative risk of electrocardiogram abnormalities in patients with SCI with intact sympathetic innervation to the heart (injury level T6 and below) compared to impaired sympathetic activity (injury level T5 and above) (2008) (0)
- Appendix G. Table 6a, Specific adverse effects for the alpha-2-delta ligands trials Part C (2012) (0)
- Table F34, Observational studies of the association between control and systematic outcomes and tumor characteristics (2009) (0)
- Table 16, Mean change from baseline for Block Design (raw score), CABG studies. Higher scores indicate a better result (2014) (0)
- Figure, Search Strategies (2011) (0)
- Table 18, Overview of Therapies for Arterial Ulcers, Mixed Lower Extremity Ulcers, and Amputation Wounds (2012) (0)
- Table 12-2, Outline of questions for judging the quality of individual studies of prognostic tests (2012) (0)
- Appendix C, Table 12, Usual Source of Care (2011) (0)
- Table F4, Age adjusted cumulative incidence of DCIS per 100,000 female population (results from individual studies conducted in different countries) (2009) (0)
- PSA Testing in Prostate Cancer: Early Treatment vs Observation (2014) (0)
- Appendix F. Figure 1, IRLS Remitters analyses (2012) (0)
- Table 1, Mean change from baseline for Trail Making A (time in seconds), CABG studies. Lower scores indicate a better result (2014) (0)
- Appendix Table E9, Femoral neck - continuous functional outcomes from studies with extractable data (2009) (0)
- Prostat kanserine müdahale (2004) (0)
- Table 8, Patient Satisfaction and Patient Preference for Teledermatology Studies (KQ3) (2010) (0)
- Major Update 2: Remdesivir for Adults With COVID-19 (2022) (0)
- Figure 1, Flowchart of future research needs process (2012) (0)
- Table F23, The role of MRI in DCIS (2009) (0)
- Table 10, Ulcer Size, Ulcer Duration, and Definitions of Closure: Hyperbaric Oxygen Therapy versus Standard Care/Sham (2012) (0)
- Evidence Tables: Dental Procedures and Oral Surgery (2019) (0)
- Figure 5, Linkages between key questions (2009) (0)
- Figure 4, Proportion of Diabetic Ulcers Healed – Platelet-Derived Growth Factor versus Comparator (2012) (0)
- Appendix G. Table 4, Withdrawals and adverse effects for the alpha-2-delta ligands trials Part A (2012) (0)
- Table 28, Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (2009) (0)
- Table 1, Summary of diagnostic comparisons in included studies (2011) (0)
- Table 29, Association between treatment and patient outcomes, stratified by architecture (2009) (0)
- ParticipationAfterMultidisciplinary Rehabilitation forModerate to Severe Traumatic Brain Injury in Adults: A Systematic Review (2013) (0)
- Table 20, Probiotic or prebiotic interventions for prevention of initial and recurrent CDI (2011) (0)
- Table 4, Studies for Reporting Diagnostic Concordance between Teledermatology and Usual Care (In-Person Dermatology) (KQ1b)* (2010) (0)
- Table 15, All-cause mortality (# subjects / # randomized) for vancomycin versus metronidazole (2011) (0)
- Figure 36, Chemoprevention of DCIS with tamoxifen (results from randomized trials) (2009) (0)
- Table 2, Effect Sizes for Trials of Quality Improvement Strategies to Improve the Antimicrobial Selection Decision (Ranji 2006, Steinman 2006) (2014) (0)
- [Table], Diagnostic Accuracy, Diagnostic Concordance, Management Accuracy, Management Concordance (2010) (0)
- Table 4, Exclusion criteria (2012) (0)
- Table 36, Ongoing studies related to DCIS registered in www.clinicaltrials.gov (2009) (0)
- Table 15, Percent change in osteodensitometric values after administration of dairy products in children consuming low lactose diets (RCTs) (2010) (0)
- Figure 15, Association between ever use of oral contraceptives and DCIS in subgroups by family history of breast cancer and menopausal status (multivariate adjusted odds ratio from the study based on the Connecticut Tumor Registry) (2009) (0)
- Appendix F. Table 15, Clinical global impressions (CGI) responders (much-very much improved) at end of treatment for the dopamine agonist studies (2012) (0)
- Table 18, Case study characteristics (2008) (0)
- Table 5, Prevalence of lactose malabsorption by challenge (2010) (0)
- [Table, Key Question 1 - literature search string]. (2008) (0)
- Table 7, Prevalence of adult-type hypolactasia genotype (2010) (0)
- Future Research Needs (2014) (0)
- Table 25, Testosterone Treatment: Improvement in Erections (2009) (0)
- Figure 11, Femoral neck - mortality for node 2 internal fixation plate and screw vs. screw/pins (2009) (0)
- Risk prediction models for diabetic foot ulcer development or amputation: a review of reviews (2023) (0)
- Table 5, Physical Environment Outcomes (2012) (0)
- Figure 9, Bone mineral content from RCTs of dairy product use in children and adolescents with low lactose diets. Femoral neck (2010) (0)
- Table 2, Methods of assessment (2012) (0)
- Table F9, Association between age at first birth and DCIS (2009) (0)
- Table F193, The changes in self-reported fecal incontinence after radiotherapy of prostate cancer in 166 males compared to active surveillance (2007) (0)
- Figure 33, Annual incidence of DCIS per 1,000 screening mammograms from January 1996 to December 1999 among age catogires of U.S. women depending on screening status (resutls from seven regional mammography registries) (2009) (0)
- Table 11-2, ACCE model questions for reviews of genetic tests (2012) (0)
- [Table, Appendix D: Patient Inclusion and Exclusion Criteria]. (2008) (0)
- THERAPY DESCRIPTIONS AND REFERENCES (2012) (0)
- Table 6, Outcomes Reported in Studies of Delayed Prescribing (2014) (0)
- Table 10, Serious Adverse Events in Sidenafil vs. Placebo (data from RCTs) (2009) (0)
- Figure 1, Flow Chart for Key Questions (2008) (0)
- Appendix G. Table 1, Withdrawals and adverse effects for the dopamine agonist trials Part A (2012) (0)
- Table 2, Incidence of Delirium - Pharmacologic Prevention Studies (2011) (0)
- 318 CHANGES IN INITIAL EXPENDITURES FOR BENIGN PROSTATIC HYPERPLASIA EVALUATION IN THE MEDICARE POPULATION (2011) (0)
- Table C, Summary and strength of evidence (SOE) of effectiveness and comparative effectiveness of multidisciplinary postacute rehabilitation for TBI (2012) (0)
- Figure 6, Goal Attainment for Diabetes, Dyslipidemia, Hypertension, and Polypharmacy Studies Based on Primary Outcome (RCTs Only) (2015) (0)
- Table 13, Description of exercise intervention studies with carbohydrate related outcomes in people with SC (2008) (0)
- [Figure], Figure 4. Symptom severity outcomes by level of provider integration (2008) (0)
- Appendix C, Table 3, Cancer Care (2011) (0)
- Figure 6, Time trend in age adjusted annual incidence of DCIS per 100,000 females (results from individual studies) (2009) (0)
- Supporting Tables: Comparative Effectiveness of Trials Across Intervention Types (2015) (0)
- [Figure], Figure 2. Hepatitis B analytic framework (2008) (0)
- Figure 1, Analytic Framework for the Diagnosis and Treatment of Erectile Dysfunction (2009) (0)
- Figure 69, Mean per-patient percent absolute change from baseline in SEP-Q2 (2009) (0)
- Table 2, Human Resource Practices – Strength of Evidence for Key Outcomes (2012) (0)
- Table 2, Comparisons of immunoassays for toxins A and B (2011) (0)
- Table 12, Process or program outcomes and utilization (2008) (0)
- [Table, Technical Expert Panel Members and Affiliation]. (2011) (0)
- Relevant Ongoing Studies (2013) (0)
- Table 7, Description of care management (2008) (0)
- Supporting Tables and Figures: Anticholinergics (2016) (0)
- Table 3, Goal Attainment - Cardiovascular Diseasesa (6 studies) (2015) (0)
- Table 8, Summary of Baseline Characteristics: Negative Pressure Wound Therapy (2012) (0)
- Table 17, Effect of increased dairy intake on bone health in young and pre-menopausal women consuming low lactose diets (results from individual RCTs) (2010) (0)
- [Table, Key Questions 2–4 - literature search strings]. (2008) (0)
- Table 4, Prevalence of Hypogonadism in Men with Erectile Dysfunction (serum bioavailable testosterone) (2009) (0)
- Figure 3, Flow Diagram – Delirium Prevention Studies (2011) (0)
- 2Management Benign prostatic hyperplasia. Part (2008) (0)
- Appendix F. Table 1, IRLS responders (≥ 50% score reduction) at end of treatment for the dopamine agonist studies (2012) (0)
- Appendix B. Data Assessment, Data Abstraction and Quality Assessment Forms (2009) (0)
- SIMULATING A RANDOMIZED TRIAL BETWEEN ADJUVANT AND SALVAGE RADIATION THERAPY AFTER PROSTATECTOMY: A MARKOV COHORT ANALYSIS (2009) (0)
- Table 3, Descriptions of secondary outcomes scales (2012) (0)
- Supporting Tables: Mirabegron (2016) (0)
- Table 34, Summary evidence map: Patient outcomes across treatments (2009) (0)
- Table F26, Summary of characteristics of included observational studies (2009) (0)
- [Table], Evidence Table C10. Off Label Treatments (2009) (0)
- Table 3, Evidence Summaries for the Randomized Pharmacologic Delirium Studies: Incidence of Delirium (2011) (0)
- Figure 4, Evans/Jensen classification for stable/unstable intertrochanteric fractures. (2009) (0)
- [Table], Reviewer Comments Export (2015) (0)
- Table F8, Association between external hormone use and DCIS (2009) (0)
- PEER REVIEWER COMMENTS (2009) (0)
- Table 5, Goal Attainment - Diabetes Mellitus (24 studies) (2015) (0)
- Appendix F. Table 9b, Self-rated quality of daytime sleepiness for dopamine agonist trials: Epworth Sleepiness Scale (2012) (0)
- Table 15, Diet and pharmacologic therapy studies for prevention and/or treatment of carbohydrate and lipid metabolism disorders in people with spinal cord injury and disease (2008) (0)
- Figure 29, Multivariate adjusted relative risk of DCIS in association with aspirin and nonsteroidal anti-inflammatory agents (results from the Iowa Women’s Health Cohort Study) (2009) (0)
- Figure 1, Trends in the incidence of DCIS and invasive cancer (1975–2005) (2009) (0)
- Editorial comment. (2010) (0)
- Evidence Tables and Figures (2008) (0)
- Withdrawals and Adverse Events Tables (2012) (0)
- Figure 20, Association between parity and DCIS (2009) (0)
- Table 9, Characteristics of included studies (2008) (0)
- Table 19, Intra-urethral Treatment: Patients with Adverse Events (2009) (0)
- Safe and Effective Anticoagulation in the Outpatient Setting (2011) (0)
- RISK OF BIAS TABLES (2015) (0)
- Table 7, Goal Attainment - Hypertension (15 studies) (2015) (0)
- [Figure], Figure 5. Diabetes prevalence, SCI vs. Control (2008) (0)
- Table F35, Outcomes after mastectomy compared to lumpectomy in women with DCIS (observational studies) (2009) (0)
- Table 5, Patient, hospital, and rehabilitation covariates from 81 RCT articles (2009) (0)
- Saw palmetto did not differ from placebo for benign prostatic hyperplasia in men. (2006) (0)
- Figure 6, Effects of active treatments compared to placebo on HBsAg loss at followup off the treatment (results from individual RCTs) (2008) (0)
- In reply [3] (2006) (0)
- Figure 31, Cumulative incidence of DCIS per 1,000 mammograms from 1996–1999 (2009) (0)
- Baseline Characteristics Tables (2012) (0)
- [Figure], Figure 3. Matrix Integration (2008) (0)
- Table F24, Accuracy and surgical impact of magnetic resonance imaging in detection of multifocal and multicentric ductal carcinoma in situ (modified from systematic review and meta-analysis) (2009) (0)
- Table 9, Association between low lactose diets and bone fractures (2010) (0)
- Table F28, Total breast cancer mortality (2009) (0)
- Table 2, Treatments of hepatitis B: Overview of randomized controlled trials (2008) (0)
- Figure 14, Short-term harms of treatment with alpha-2-delta ligands: any study withdrawals (2012) (0)
- Figure 16, Significant effects on combined virological and biochemical outcomes at follow up after drug therapies for chronic hepatitis B (significant risk differences from individual RCTs and pooled with random effects model) (2008) (0)
- Table 4, Characteristics of Included Studies with Level of Evidence Rating (2013) (0)
- Figure 23, HBeAg loss and seroconversion at followup off drug therapies for chronic hepatitis B by patient pretreatment status, baseline HBeAg positivity, and the proportion of the patients with baseline cirrhosis, results from individual studies (2008) (0)
- Figure 43, IIEF-EF ≥ 26 at follow up (weeks 10–12) (2009) (0)
- Figure 42, Improved erection without Carson 2004 (GAQ-Q1) (2009) (0)
- Figure 3, AO/OTA classification of proximal femur fracture (2009) (0)
- Figure 2, Quality of Store and Forward Studies (N=41) (2010) (0)
- SPECIFIC ASSOCIATION OF RCE LEVEL OF EVIDENCE RATINGS TO QUADAS ITEM RATINGS AS APPLIED IN THIS REVIEW (2013) (0)
- Table 25, Impact of tumor grade on the effectiveness of lumpectomy plus radiation vs. lumpectomy alone (2009) (0)
- Table 8, Effects of antiviral drugs for chronic hepatitis B on off treatment outcomes in patient subpopulations (2008) (0)
- [Figure], Figure 17. Odds ratios* of cardiovascular outcomes in VA users with SCI and diabetes vs. SCI but no diabetes (2008) (0)
- Table 15, Association between microinvasion and patient outcomes (2009) (0)
- Table 14, Integrated care trials by target patient age (2008) (0)
- Figure 3, Comparative effectiveness of interferon alfa-2b and reverse transcriptase inhibitors on mortality, results from individual randomized controlled clinical trials (2008) (0)
- Table F38, Observational studies of control and systemic outcomes stratified by mastectomy (2009) (0)
- Figure 9, Proportion of Venous Ulcers Healed - Keratinocytes versus Standard Care (2012) (0)
- Cognitive Outcomes Tables: Individual Neuropsychological Tests/Cognitive Domains (2014) (0)
- [Figure], Figure 6. Prevalence of diagnosed diabetes, undiagnosed diabetes, and impaired fasting glucose in men (NHANES 1999-2002) (2008) (0)
- Table 3, Second topical research need research design considerations (2013) (0)
- Table 31, Association between treatment and patient outcomes, stratified by microinvasion status (2009) (0)
- Risk of Bias and Study Quality (2016) (0)
- Table E8, Number of subjects with laboratory abnormalities from RCTS (2008) (0)
- Table E1, Evidence table: Observational studies of the natural history of chronic hepatitis B in adults (2008) (0)
- Table 12, Intracavernosal Injection: Sexual Intercourse Success (2009) (0)
- Appendix Table E5, Intertrochanteric evidence-2 (2009) (0)
- Efficacy of Long-Term Osteoporosis Drug Treatment (2019) (0)
- Table 14, Mean days to resolution of diarrhea/clinical improvement for all other standard treatment trials (2011) (0)
- Barriers and facilitators of evidence-based psychotherapies for chronic pain in adults: A systematic review. (2023) (0)
- Figure 28, Dyspepsia (treatment-related): patients with hypertension taking anti-hypertensive drugs (2009) (0)
- Table 2, Prevalence of Hypogonadism in Men with Erectile Dysfunction (serum total testosterone) (2009) (0)
- Table 6, Percent of all deaths from CVD among adults with SCI (2008) (0)
- Table 17, Uses of health information technology to improve integration processes of care (2008) (0)
- Table 18, Association between ER status and outcomes (2009) (0)
- CRITERIA USED IN QUALITY ASSESSMENT OF NON-RANDOMIZED STUDIES (2012) (0)
- Table 6, Surgeon factors reported in 81 RCT articles (2009) (0)
- Table 33, Adverse events after compared treatments (2009) (0)
- Levels of Evidence (2009) (0)
- Figure 5, Incidence of Delirium, Randomized Pharmacologic Trials (2011) (0)
- Table 2, Excerpt from “Future Research Needs for Attention Deficit Hyperactivity Disorder” (2012) (0)
- Table 3, Prevalence of lactose intolerance symptoms following challenge (2010) (0)
- Analytical Framework and Search Strategies (2016) (0)
- Figure 6, Association between dairy calcium intake (mg/day) and bone fractures (2010) (0)
- Figure 15, Short-term harms of treatment with alpha-2-delta ligands: study withdrawals due to adverse events (2012) (0)
- Figure 8, Proportion of Venous Ulcers Healed - Biological Skin Equivalent (Dermagraft) versus Compression Bandage (2012) (0)
- Table 11, Community integration questionnaire (2012) (0)
- Table 4, Outcomes Reported in Studies of Provider Feedback (2014) (0)
- Table F41, Observational studies of control and systemic outcomes stratified by lumpectomy + radiation therapy (2009) (0)
- [Table, Relevant Ongoing Studies]. (2013) (0)
- Figure 3, The mean IIEF “EF domain” score (2009) (0)
- [Table, SEARCH STRATEGY]. (2010) (0)
- Correction: Previously Undisclosed Potential Conflict of Interest by an Author of American College of Physicians Clinical Guidelines (2023) (0)
- Table F112, Effects of medical devices on self reported severity of urinary incontinence, quality of life, and objective instrumental measures of severity (continuous variables) (2007) (0)
- Table 6, Mean change from baseline for Rey Auditory Verbal Learning Test (number of words), Carotid artery stenting (CAS) studies. Higher scores indicate a better result (2014) (0)
- References to Appendixes (2012) (0)
- Figure 18, Association between DCIS and age at first live birth among different age categories (2009) (0)
- Table 9, Outcomes Reported in Studies of Clinical Decision Support (2014) (0)
- Impact of a Low-Cost Intervention to Increase Cholesterol Awareness Among Older Patients (2000) (0)
- Table 3, Outcomes Reported in Studies of Provider and/or Patient Education (2014) (0)
- Appendix Table D7, Association between lactose intake and metabolism and bone density (BD) (2010) (0)
- Table 1, Hip fracture management characteristics (2009) (0)
- USPSTF RECOMMENDATIONS FOR SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS IN WOMEN (2013) (0)
- [Table, Overall ranking of evidence]. (2010) (0)
- Appendix I. List of Unobtained Articles (2009) (0)
- Appendix B: Search String (2008) (0)
- Figure 11, Association between ever use of hormone replacement therapy and DCIS (2009) (0)
- Table F7, Association between race and DCIS (2009) (0)
- Table 5, Population Characteristics of Studies Measuring Hyperprolactinemia in Men with Erectile Dysfunction (2009) (0)
- Table 28, Impact of grade on the effectiveness of mastectomy vs. lumpectomy (2009) (0)
- Figure 46, Serious adverse events (2009) (0)
- Appendix C, Table 7, Neurologic Conditions (2011) (0)
- Table 2, Primary outcome scales measuring community integration (2012) (0)
- Table 4, Mean change from baseline for Verbal Fluency, CABG studies. Higher scores indicate a better result (2014) (0)
- Table F20, Cumulative incidence of DCIS per 1,000 mammograms among U.S. females (2009) (0)
- Figure 6, Conceptual model (2009) (0)
- Orthobiologics in Foot and Ankle Arthrodesis: A Systematic Review. (2021) (0)
- Figure 3, Conceptual model for question 2 (2009) (0)
- Table 11, Strength of Evidence - Advanced Wound Care Therapies for Diabetic Ulcers (2012) (0)
- Figure 22, Adjusted odds ratios of DCIS by mammographic breast density (results from the Multiethnic cohort (2009) (0)
- Executive Summary Table 2b, Overview of Patient Outcomes - Antimicrobial Stewardship Interventions for Outpatients (2014) (0)
- Table 9, Incidence of SLN metastases among patients with either DCIS or DCISM (2009) (0)
- Table 32, Effect of tamoxifen on patient outcomes (results from RCTs) (2009) (0)
- Appendix E: Evidence Table (2008) (0)
- Table 11-3, Questions for assessing preanalytic, analytic, and postanalytic factors for evaluating predictive genetic tests* (2012) (0)
- Appendix Table E13, Intertrochanteric mortality (2009) (0)
- Figure 63, Absolute mean change from baseline in IIEF-EF score (2009) (0)
- Table 11, Clinical recurrence: # subjects / # initially cured (percent) for vancomycin versus metronidazole (2011) (0)
- Table 2, Summary of prior reviews involving some form of integrated care for persons with mental illness (2008) (0)
- Figure 10, Proportion of Venous Ulcers Healed – Silver Products (2012) (0)
- Table 7, Overview of primary outcomes with strength of evidence (2012) (0)
- Figure 39, Successful intercourse attempts (SEP-Q2) (2009) (0)
- Figure 24, Family history of breast or ovarian breast cancer and DCIS (2009) (0)
- Table 3, Diagnosis of DCIS and invasive cancer among screened populations (2009) (0)
- Figure 9, Efficacy outcomes for treatment with alpha-2-delta ligands: IRLS responders (≥50% scale score reduction) (2012) (0)
- Table F25, Treatment utilization and patient outcomes in relation to sentinel node biopsy in patients with DCIS (2009) (0)
- Appendix A: Technical Expert Panel Members and Affiliation (2008) (0)
- Figure 7, Study Quality of Organizational Culture Non-Randomized Studies (2012) (0)
- Table 7, Adverse Events and Mortality – Prevention Studies (2011) (0)
- Appendix D, Table 4, Primary Prevention Outcomes of Non-Pharmacologic or Mixed Studies (2011) (0)
- Table 2, Included devices (2009) (0)
- Figure 16, Patients with ≥1 adverse effect, dopamine agonist trials (2012) (0)
- Supporting Tables and Figures: PDE-5 Inhibitors (2016) (0)
- Table 8, Responders to treatment, Clinician-rated global impressions (CGI) responders: participants who reported improved or much improved: absolute effect per 100 patients (2012) (0)
- Figure 2, Minimum Time from End of Bowel Preparation to Procedure (Blue Lines) or Time Before Procedure when Liquids were Stopped (Red Lines) (2015) (0)
- Figure 23, The mean IIEF-Q4 score: patients with hypertension taking anti-hypertensive drugs (2009) (0)
- Table E16, Completed unpublished RCTs in patients with chronic hepatitis B (2008) (0)
- In prostate cancer, urinary and sexual function were worse with prostatectomy than active monitoring or radiotherapy (2016) (0)
- Table 17, Intra-urethral Treatment: Sexual Intercourse (2009) (0)
- Table 1, Summary of Baseline Characteristics (2015) (0)
- Table 4, Goal Attainment - Chronic Kidney Disease (4 studies) (2015) (0)
- Table 9, Productivity outcomes (2012) (0)
- Table 6, Characteristics of studied interventions (2012) (0)
- Figure 3, Completion Rate, Adenoma Detection Rate, and Diagnostic Yield: Outcomes from Randomized Controlled Trials (2015) (0)
- Table 21, Mean change from baseline for the Montreal Cognitive Assessment, CEA studies. Higher scores indicate a better result (2014) (0)
- Table F3, Age adjusted cumulative incidence of DCIS per 100,000 U.S. female population (results from individual studies conducted in the United States are sorted by the year of the events) (2009) (0)
- Table 8, Summary of study population characteristics (primary outcome studies with low of moderate risk of bias) (2012) (0)
- Table 1, Summary of Included Studies (2015) (0)
- Figure 3, Supplemental prevention framework (2011) (0)
- Table 11, Mean change from baseline for Grooved Pegboard Test (seconds), CABG studies. Lower scores indicate a better result (2014) (0)
- Figure 1, Literature flow diagram (2011) (0)
- Table 27, Miscellaneous Treatments: Efficacy and Adverse Events (2009) (0)
- Appendix C, Table 10, Medical Procedures and Diagnostic Tests (2011) (0)
- Appendix F. Table 4, International Restless Legs Study Group Rating Scale (IRLS) scores for the cabergoline studies (2012) (0)
- Figure 4, Association between milk intake and hip fracture (2010) (0)
- Table F16, Association between breast condition and DCIS (2009) (0)
- Table 11, Association between genetic polymorphism and bone fractures (2010) (0)
- Figure 26, Any adverse event (all cause): patients with hypertension taking anti-hypertensive drugs (2009) (0)
- Table F31, Total local DCIS or Invasive (2009) (0)
- Appendix F. Figure 8, Funnel plot for Mean change in IRLS total score from baseline (2012) (0)
- Figure 11-1, Generic analytic framework for evaluating predictive genetic tests (2012) (0)
- Table 8, Diabetes management and diabetes complications in VA users with SCI, in VA users without SCI, and non-VA user general population without SCI (2008) (0)
- Sample Abstraction Forms (2008) (0)
- Table 20, Mean change from baseline for Mini Mental State Exam, CEA studies. Higher scores indicate a better result (2014) (0)
- Table 8, Outcomes – Intensive Care Unit Diagnostic Accuracy Studies (2011) (0)
- [Figure], Figure 14. Mean BMI, SCI, and Control (2008) (0)
- Table 12, Clinical recurrence: # subjects / # initially cured (percent) for all other standard treatment trials (2011) (0)
- Table 6, Studies Comparing More than One Screening Instrument (2013) (0)
- Evaluation of Implementation Strategies for Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Mindfulness-Based Stress Reduction (MBSR): a Systematic Review (2023) (0)
- Systematic Reviews and Meta-Analyses (2006) (0)
- [Figure], Figure 12. Total cholesterol, LDL-C and triglyceride levels of able-bodied males by age (NHANES) (2008) (0)
- Risk of Bias Assessment Instrument and Instructions (2016) (0)
- Table 1, Summary of Study Baseline Characteristics for Delirium Prevention Studies (2011) (0)
- Figure 5, Efficacy outcomes for treatment with dopamine agonists: proportion of study participants who reported improved or much improved on patient-rated global impressions scale (PGI) (2012) (0)
- Table 5, Incidence of Delirium - Non-Pharmacologic or Mixed Treatments Prevention Studies (2011) (0)
- Appendix G. Table 2, Adverse effects for the dopamine agonist trials Part B (2012) (0)
- Appendix Figure E2, QUORUM statement data for observational literature (2009) (0)
- Cognitive Outcomes Tables: Incident Cognitive Impairment Defined by Composite of Neuropsychological Tests (2014) (0)
- [Figure], Figure 2. QUORUM Statement Data (2008) (0)
- [Table], Evidence Table C2. Oral Vardenafil (2009) (0)
- Healthcare Overuse: A Literature Review and Taxonomy Proposal (2016) (0)
- Table 3, Patient outcomes used in literature (2009) (0)
- [Table, Appendix F: Conceptual Definition of Outcomes]. (2008) (0)
- Figure 5a, Aggregated Diagnostic Concordance of Store and Forward Studies (2010) (0)
- Table 17, Mean change from baseline for Boston Naming Test or Vocabulary WAIS III, CABG studies. Higher scores indicate a better result (2014) (0)
- Corrigendum re: "Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)" [Eur Urol 2020;77:713-24]. (2021) (0)
- Figure 30, Percent change in the age-adjusted incidence of DCIS, invasive breast cancer, and mammography (2009) (0)
- Table 5, Absolute risk difference in tested nonclinical outcomes after antiviral drugs for chronic hepatitis B in adults (2008) (0)
- Appendix Table E8, Femoral neck – categorical functional outcomes from studies with extractable data (2009) (0)
- Figure 11, Visual disturbances (all cause) (2009) (0)
- Chronic Urinary Retention (2014) (0)
- Appendix F. Figure 7, Fixed-dose analyses of harms: Dopamine agonists (2012) (0)
- Screening for Breast Cancer in Average-Risk Women (2019) (0)
- Table F39, Observational studies of control and systemic outcomes and treatment based on multivariate analysis (2009) (0)
- Table E2, Evidence table: Randomized controlled trials for treatment of hepatitis B (2008) (0)
- Table 18, Outcomes for all standard treatment trials (2011) (0)
- Appendix H. Instruments Used in the Assessment of Treatment Outcomes (2009) (0)
- Figure 5b, Primary Diagnostic Concordance of Store and Forward Studies (2010) (0)
- Table 3, Prevalence of cardiovascular symptoms* and hypertension depending on level on injury (2008) (0)
- Table 21, Comparison of major prognostic factors between DCIS and early stage invasive breast cancer (2009) (0)
- [Figure], Figure 6. Remission rate by level of provider integration (2008) (0)
- Appendix F. Table 10b, Self-rated quality of daytime sleepiness for alpha-2-delta ligands trials: Epworth Sleepiness (2012) (0)
- Figure 9, Association between age at menarche and DCIS (2009) (0)
- Figure 7b, Management Concordance of Live Interactive Studies (2010) (0)
- Table 2, Physical Examination Procedures Not Evaluated by the USPSTF (for Average Risk Asymptomatic Adults) (2011) (0)
- Figure 27, Headache (treatment-related): patients with hypertension taking anti-hypertensive drugs (2009) (0)
- Table 1, Effect Sizes for Trials of Quality Improvement Strategies to Improve the Treatment Decision (Ranji 2008) (2014) (0)
- Risk of Bias and Quality (2014) (0)
- Appendix D. Table 1, Secondary outcomes (2012) (0)
- PSA screening for prostate cancer: Addressing counseling controversies and clinical questions (2003) (0)
- Table 14, Intracavernosal Injection: Patients with Adverse Events (2009) (0)
- Figure 28, Association between physical activity and DCIS (adjusted odds ratios from the Cancer Surveillance Program and the Women’s Contraceptive and Reproductive Experiences Study) (2009) (0)
- Appendix C, Table 1, Preventive Care/Ambulatory Care Sensitive Conditions (2011) (0)
- Appendix F. Figure 4, Efficacy and Harms data for double-blind Cabergoline trials (2012) (0)
- Figure 2, Garden classification for femoral neck fractures (2009) (0)
- Table 12, Overview of Therapies for Venous Ulcers (2012) (0)
- Table 10, Teledermatology Studies Reporting Cost Outcomes (KQ4) (2010) (0)
- Table F29, Total distant metastasis (2009) (0)
- Table E13, Evidence table of the studies that examined the association between changes in intermediate outcomes to predict treatment effectiveness (n=4) (2008) (0)
- Appendix Table E11, Intertrochanteric - categorical functional/pain outcomes from studies with extractable data (2009) (0)
- Figure 8, Efficacy outcomes for treatment with dopamine agonists: change in sleep (MOS) scores (2012) (0)
- Table E7, Number of subjects experiencing adverse events from RCTs (2008) (0)
- Table 12, Strength of evidence for the primary TBI studies: CIQ (2012) (0)
- [Figure], Figure 4. Flow chart for Question 3a references (exercise/physical activity interventions) (2008) (0)
- Table F42, Observational studies of control and systemic outcomes stratified by LRT (2009) (0)
- Table 7, Responders to treatment, International Restless Legs Syndrome Study Group Rating Scale responders (≥50% score reduction): Absolute effect per 100 patients (2012) (0)
- [Figure], Figure 14. WCHO funding mechanisms (2008) (0)
- Table 8, Confidence Scores for Neurologic Conditions Studies (2011) (0)
- Table 13, Mean days to resolution of diarrhea/clinical improvement for vancomycin versus metronidazole (2011) (0)
- Appendix A. Search Strategies (2009) (0)
- Table C67, Significant differences in age adjusted rate/100,000 male population (pooled analysis) (2008) (0)
- Figure 1, Diagram of right hip as viewed from the front (2009) (0)
- Table 4, Confidence Scores for Cancer Care Studies (2011) (0)
- Appendix B. Table 1, Risk of Bias for Individual Studies (2012) (0)
- Figure 2, Flow Diagram of Included Studies (2011) (0)
- Appendix D, Table 2, Primary Prevention Outcomes of Pharmacologic Studies (2011) (0)
- Table F32, Total Local DCIS (2009) (0)
- Figure 21, Subtrochanteric – mortality for plate/screw comparisons (2009) (0)
- Table 5, Mortality from CVD in adults with SCI (2008) (0)
- Secondary Stone Recurrence Outcomes Tables (2012) (0)
- Table 11, Key Elements for Success and Barriers to Implementation (2010) (0)
- Appendix F. Table 12, Self-rated quality of sleep for the non-pharmacologic trials (2012) (0)
- Critical thinker: a conversation with health services researcher (interview by Carmen Peota). (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Timothy J. Wilt?
Timothy J. Wilt is affiliated with the following schools:
